def14a

Please indicate if you plan to attend the 2008 Annual
Shareholders’ Meeting.

Please date and sign as name appears hereon. If shares are held jointly or by two or more persons, each shareholder named should sign. Executors, administrators, trustees, etc. should so indicate when signing. If the signer is a corporation, please sign full corporate name by duly authorized officer. If a partnership, please sign in partnership name by authorized person.

Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )


	Filed by the Registrant x
	Filed by a Party other than the Registrant o

	Check the appropriate box:


	o Preliminary Proxy Statement
	o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
	ý Definitive Proxy Statement
	o Definitive Additional Materials
	o Soliciting Material Pursuant to §240.14a-12


	x No fee required.
	o Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.


	3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):


	o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

April 16, 2008

Dear Shareholder:

You are cordially invited to attend the Annual Shareholders’ Meeting of Cerner Corporation (the “Company”) to be held at 10:00 a.m., local time, on May 23, 2008, at The Cerner Round auditorium in the Cerner Vision Center, located on the Cerner campus at 2850 Rockcreek Parkway, North Kansas City, Missouri 64117.

Details of the business to be conducted at the Annual Shareholders’ Meeting are given in the attached Notice of Annual Meeting and Proxy Statement. We will also report on matters of current interest to our shareholders. We hope you will be able to attend the meeting. However, even if you plan to attend in person, please vote your shares promptly to ensure they are represented at the meeting. You may submit your proxy vote by telephone or Internet as described in the following materials or by completing and signing the enclosed Proxy Card and returning it in the envelope provided. If you decide to attend the meeting and wish to change your proxy vote, you may do so automatically by voting in person at the meeting.

Promptly voting by Internet or telephone or returning your Proxy Card in the enclosed postage prepaid envelope will help ensure that as many shares as possible are represented.

Very truly yours,
CERNER CORPORATION

Neal L. Patterson
Chairman of the Board of Directors and
Chief Executive Officer

CERNER CORPORATION
2800 ROCKCREEK PARKWAY
NORTH KANSAS CITY, MISSOURI 64117

NOTICE OF ANNUAL SHAREHOLDERS’ MEETING
MAY 23, 2008

TO OUR SHAREHOLDERS:

The Annual Shareholders’ Meeting of Cerner Corporation will be held on May 23, 2008, at 10:00 a.m. local time, at our corporate headquarters, 2850 Rockcreek Parkway, North Kansas City, Missouri 64117, at The Cerner Round auditorium in the Cerner Vision Center, for the following purposes:

	1.		The election of three Directors, John C. Danforth, Neal L. Patterson and William D. Zollars, each to serve for a three year term (see page 36 of the Proxy Statement);

	2.		The ratification of the appointment of KPMG LLP as the independent registered public accounting firm of Cerner Corporation for 2008 (see page 37 of the Proxy Statement); and,

	3.		Any other business that may properly come before the Annual Shareholders’ Meeting or any adjournment thereof.

These items are more fully described in the following pages, which are made part of this notice.

The holder of record of each share of our common stock at the close of business on March 28, 2008 is entitled to receive notice of and to vote at the Annual Shareholders’ Meeting or any adjournment or postponement of the meeting. Shares of common stock can be voted at the Annual Shareholders’ Meeting only if the holder is present in person or by valid proxy. The Board of Directors of Cerner Corporation solicits you to sign, date and promptly mail the Proxy Card in the enclosed postage prepaid envelope or to vote your shares by telephone or the Internet, regardless of whether or not you intend to be present at the Annual Shareholders’ Meeting. You are urged, however, to attend the Annual Shareholders’ Meeting.

A copy of our Annual Report to Shareholders, which includes audited consolidated financial statements, is enclosed. The Annual Report is not part of our proxy soliciting material.

BY ORDER OF THE BOARD OF DIRECTORS,

Randy D. Sims
Secretary

You may vote your shares by telephone, via the Internet or by mail by following the instructions on your Proxy Card. If you vote by telephone or via the Internet, you should not return your Proxy Card. If you choose to vote by mail, please sign, date and return the Proxy Card in the envelope provided. The Proxy may be revoked at any time before your shares are voted at the meeting by submitting written notice of revocation to the Secretary of Cerner Corporation or by submitting another timely proxy by telephone, Internet or mail. If you are present at the meeting, you may choose to vote your shares in person, and the Proxy will not be used. If you hold shares through a broker or other custodian, please check the voting instructions used by that broker or custodian.

CERNER CORPORATION
2800 ROCKCREEK PARKWAY
NORTH KANSAS CITY, MISSOURI 64117

PROXY STATEMENT

2008 ANNUAL SHAREHOLDERS’ MEETING
MAY 23, 2008

This Proxy Statement, which is being mailed on or about April 16, 2008, is furnished to you in connection with the solicitation of proxies by the Board of Directors (the “Board”) of Cerner Corporation, a Delaware corporation (the “Company”), for use at the Annual Shareholders’ Meeting of the Company to be held on May 23, 2008, commencing at 10:00 a.m., local time, at The Cerner Round auditorium in the Cerner Vision Center, located on the Cerner campus at 2850 Rockcreek Parkway, North Kansas City, Missouri 64117, and any adjournment thereof. Your vote is very important. For this reason, the Board is requesting that you allow your Common Stock to be represented at the Annual Shareholders’ Meeting by the persons named as proxies on the Proxy Card.

GENERAL INFORMATION


Who can vote?		You are entitled to vote your outstanding shares of common stock, par value $.01 per share, of the Company (“Common Stock”) if our records show that you held your shares as of March 28, 2008, the record date for our meeting. At the close of business on that date, 80,487,678 shares of Common Stock were outstanding and entitled to vote. Each share of Common Stock has one vote. The Proxy Card shows the number of shares that you are entitled to vote. Your individual vote is confidential and will not be disclosed to third parties.

How do I vote?		If your Common Stock is held by a broker, bank or other nominee (i.e., in street name), you will receive instructions from it that you must follow in order to have your shares voted. The Proxy Card contains voting instructions.

		If you hold your shares in your own name (i.e., as a holder of record), you may vote your shares by mail, by telephone, over the Internet or in person. PLEASE CHOOSE ONLY ONE OF THE FOLLOWING:

	1.		By Mail: To vote by mail, you may instruct the persons named as proxies how to vote your Common Stock by signing, dating and mailing the Proxy Card in the envelope provided. If you mail your Proxy Card, we must receive it before 10:00 a.m. (CT) on Friday, May 23, 2008, the day of the Annual Shareholders’ Meeting.

			If you are returning your Proxy Card to Broadridge, they must receive it before 10:00 a.m. (ET) on Thursday, May 22, 2008, the day before the Annual Shareholders’ Meeting.

	2.		By Telephone: You may vote by telephone 24 hours a day, 7 days a week until 11:59 p.m. (ET) on May 22, 2008. If you are in the United States or Canada, you may call toll-free 1 (800) 690-6903.

			In order to vote by telephone, you need the control number on your Proxy Card. Each shareholder has a unique control number so we can ensure all voting instructions are genuine and prevent duplicate voting. If you use the telephone voting system, you do not need to return your Proxy Card.

	3.		By Internet: The website for voting is at http://www.ProxyVote.com. You may vote via the Internet 24 hours a day, 7 days a week until 11:59 p.m. (CT) on May 22, 2008.

			In order to vote on the Internet, you need the control number on your Proxy Card. Each shareholder has a unique control number so we can ensure all voting instructions are genuine and prevent duplicate voting. If you use the Internet voting system, you do not need to return your Proxy Card.

	4.		In Person: Of course, you can always come to the meeting and vote your shares in person. You can vote by any of the three methods above prior to the meeting and still attend the Annual Shareholders’ Meeting. In all cases, a vote at the Annual Shareholders’ Meeting will revoke any prior votes.


		You may receive and need to vote more than one control number based on the number of accounts in which you hold Common Stock.

How may I revoke or change my proxy instructions?		If you vote your shares, and later desire to revoke or change your vote (prior to the Annual Shareholders’ Meeting), you may revoke and then change your initial proxy instructions by any of the following procedures:

		1. Send us another signed proxy with a later date; or

		2. Follow the telephone or Internet voting instructions on how to revoke or change your vote by logging in and resubmitting your vote; or

		3. Send a letter to our Corporate Secretary revoking your proxy that is received by our Corporate Secretary before your Common Stock has been voted by the persons named as proxies at the Annual Shareholders’ Meeting; or

		4. Attend the Annual Shareholders’ Meeting and vote your shares in person.

How are votes counted?		The Annual Shareholders’ Meeting will be held if a majority of our outstanding shares entitled to vote is represented at the meeting. If you have returned valid proxy instructions or attend the meeting in person, your shares will be counted for the purpose of determining whether there is a quorum, even if you wish to abstain from voting on some or all matters introduced at the meeting. If a quorum is not present, the Annual Shareholders’ Meeting may be adjourned from time to time until a quorum is obtained.

		If you give us a proxy without giving specific voting instructions, your shares will be voted by the persons named as proxies as recommended by the Board. We are not aware of any others matters to be presented at the Annual Shareholders’ Meeting except for those described in this Proxy Statement. However, if any other matters not described in this Proxy Statement are properly presented at the meeting, the persons named as proxies will use their own judgment to determine how to vote your shares. If the meeting is adjourned, your shares may be voted by the persons named as proxies on the new meeting date as well, unless you have revoked your proxy instructions prior to that time. All votes will be tabulated by two independent individuals appointed by the Board of Directors as Inspectors of Election.


What is a broker non-vote?		A “broker non-vote” occurs when a broker or other nominee holding shares for a beneficial owner does not vote on a particular proposal because the broker or other nominee does not have discretionary voting power with respect to that item and has not received instructions from the beneficial owner. Broker non-votes are counted as present or represented for purposes of determining the presence or absence of a quorum for the Annual Shareholders’ Meeting, if such shares are otherwise properly represented at the meeting in person or by proxy. Broker non-votes are not counted for purposes of determining the number of shares entitled to vote on any proposal which the broker or other nominee lacks discretionary authority.

		If you are a beneficial shareholder and your broker holds your shares in its name, the broker is permitted to vote your shares on the election of Directors and ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm even if the broker does not receive voting instructions from you.

May I attend the Annual Shareholders’ Meeting?		If you were a holder of record on the record date, March 28, 2008, you may attend and vote at the Annual Shareholders’ Meeting. If you plan to attend the Annual Shareholders’ Meeting, please indicate this when you vote. If you want to vote in person shares you hold in street name, you will have to get a proxy in your name from your bank or broker.

What vote is required?		In an uncontested Director election, an affirmative vote of a majority of the votes cast, in person or by proxy, is required for the election of Directors. Therefore, if you elect to withhold authority to vote for any nominee, such action will be counted as a vote against the nominee; however, if you do not vote for a nominee on your Proxy Card, your vote will not count for or against such nominee. No shareholder may vote in person or by proxy for greater than three nominees at the Annual Shareholders’ Meeting. Shareholders do not have cumulative voting rights in the election of Directors.

		The proposal to ratify the appointment of KPMG LLP as our independent registered public accounting firm will be adopted upon the affirmative vote of a majority of the shares voting on the proposal. Abstentions are treated as votes “Against” the proposal.

How does the Board recommend that I vote?		The Board recommends a vote:
		• For all nominees for Director; and

		• For the ratification of the appointment of KMPG LLP as the independent registered public accounting firm of the Company for 2008.

Who pays the cost of this proxy solicitation?		The Company is paying the cost of this proxy solicitation. We will, upon request, reimburse brokers, banks and other nominees for their expenses in sending proxy material to their principals and obtaining their proxies. We will solicit proxies by mail, except for any incidental personal solicitation made by our Directors, officers and associates (employees), for which they will not be paid.

		We have engaged Broadridge as paid solicitors in connection with the Annual Shareholders’ Meeting. Broadridge will be paid to solicit proxies through the Internet, telephone and coordinate all mail votes and distribute proxy materials to nominees, brokers and institutions. The anticipated cost of such services is approximately $35,000.

Who should I call if I have questions?		If you have questions about the Annual Shareholders’ Meeting or voting, please call our Corporate Secretary, Randy Sims, at (816) 201-2556.

INFORMATION CONCERNING DIRECTORS

Our Board consists of eight persons, divided into three classes serving staggered terms of three years. The terms of our three Class I directors will expire at this year’s Annual Shareholders’ Meeting (if re-elected, their new terms will expire at the 2011 annual meeting). The terms of the Class II and Class III Directors will expire at the 2009 and 2010 annual meetings, respectively. The Board has determined that all six current non-employee members of the Board are independent directors as required by the Securities and Exchange Commission (SEC) and The NASDAQ Stock Market. The names of the Company’s Directors and information about them are set forth below.


CLASS I John C. Danforth (Age 71) Member of the: • Compensation Committee • Nominating, Governance & Public Policy Committee		Mr. Danforth was a Director of the Company from May 1996 through June 2004 when he resigned to serve as Ambassador to the United Nations, where he served from July 2004 through January 2005. Mr. Danforth was re-appointed by the Board as a Director of the Company in February 2005. Mr. Danforth represented the State of Missouri in the U.S. Senate for 18 years until 1995 and served as a Director of The Dow Chemical Company and MetLife, Inc. until June 2004. Mr. Danforth is presently a partner in the law firm of Bryan Cave LLP; an advisory member of the Board of Trustees of Eisenhower Medical Center; serves on the commission on Presidential Debates; serves as a Director of Greenhill & Co., Inc.; and, serves as Chairman of the Danforth Foundation.

Neal L. Patterson (Age 58)		Mr. Patterson has been a Director of the Company since 1980 and is a co-founder of the Company. Mr. Patterson has been Chairman of the Board of Directors and Chief Executive Officer of the Company for more than five years. Mr. Patterson also served as President of the Company from March 1999 until August 1999.

William D. Zollars (Age 60) Member of the: • Audit Committee • Compensation Committee		Mr. Zollars has been a Director of the Company since May 2005. He is currently the Chairman, President and Chief Executive Officer of YRC Worldwide, which position he has held since November 1999. Prior to 1999, Mr. Zollars served as President of Yellow Transportation, Inc. from September 1996 through November 1999. From 1994 to 1996, Mr. Zollars was Senior Vice President of Ryder Integrated Logistics, and prior to that, Mr. Zollars spent time with Eastman Kodak in various executive positions. Mr. Zollars serves on the boards of the following public companies: YRC Worldwide, ProLogis Trust and CIGNA Corporation. Mr. Zollars also serves on the boards of The Midwest Research Institute, National Association of Manufacturers, Business Roundtable, United Way of Greater Kansas City, American Trucking Associations, The Civic Council of Greater Kansas City and The Carlson School of Management at the University of Minnesota.

CLASS II Clifford W. Illig (Age 57)		Mr. Illig has been a Director of the Company since 1980 and is a co-founder of the Company. Mr. Illig served as Chief Operating Officer of the Company for more than five years until October 1998 and as President of the Company for more than five years until March 1999. Mr. Illig has served as Vice Chairman of the Board of Directors since March 1999.


William B. Neaves, Ph.D. (Age 65) Member of the: • Audit Committee • Compensation Committee • Nominating, Governance & Public Policy Committee (Chairperson)		Dr. Neaves has been a Director of the Company since March 2001. Dr. Neaves has been President, Chief Executive Officer and member of the Board of Directors of The Stowers Institute for Medical Research since June 2000. For twenty years prior to 2000, he served in succession as Dean of Southwestern Graduate School, Dean of Southwestern Medical School and Chief Academic Officer and holder of the Wildenthal Distinguished Chair in Biomedical Science at the University of Texas Southwestern Medical Center. He is presently a member of the Board of Directors of the Midwest Research Institute, the Board of Trustees of Washington University in St. Louis and the National Council of the Washington University School of Medicine.

CLASS III Gerald E. Bisbee, Jr., Ph.D. (Age 65) Member of the: • Audit Committee (Chairperson) • Compensation Committee • Nominating, Governance & Public Policy Committee		Dr. Bisbee has been a Director of the Company since February 1988. Dr. Bisbee is Chairman, President and Chief Executive Officer of ReGen Biologics, Inc. (ReGen), which develops, manufactures and markets orthopaedic tissue repair products worldwide. He has also served on the Board of Directors for ReGen since 1998. Dr. Bisbee was a Director of Aros Corporation (formerly known as APACHE Medical Systems, Inc.) commencing in December 1989, serving as Chairman of the Board from December 1989 to November 1997 and from December 2000 to June 2002. He was Chief Executive Officer of Aros from December 1989 to November 1997. In June 2002, ReGen and Aros merged. Prior to 1989, Dr. Bisbee was President of the Hospital Research and Educational Trust and also was a prior faculty member of the Department of Epidemiology and Public Health at Yale University. Dr. Bisbee is also currently a Director of CARE Investment Trust.

Nancy-Ann DeParle (Age 51) Member of the: • Audit Committee • Compensation Committee		Ms. DeParle has been a Director of the Company since May 2001. Ms. DeParle is a Managing Director of CCMP Capital and an Adjunct Professor of Health Care Systems at the Wharton School of the University of Pennsylvania. She also serves as a Commissioner on the Medicare Payment Advisory Commission (MedPAC), which advises Congress on Medicare payment and policy issues. She was Administrator of the Health Care Financing Administration (HCFA, now the Centers for Medicare and Medicaid Services) from 1997 to October 2000 and a Fellow of the Institute of Politics and the Interfaculty Health Policy Forum at Harvard University from October of 2000 to the Spring of 2001. Before joining HCFA, she served as Associate Director for Health and Personnel at the White House Office of Management and Budget from 1993 to 1997. She has also worked as a lawyer in private practice and served as the Commissioner of the Tennessee Department of Human Services and as a Director of Triad Hospitals, Inc. Ms. DeParle is currently a Director of Boston Scientific and DaVita, Inc.

Michael E. Herman (Age 66) Member of the: • Compensation Committee (Chairperson)		Mr. Herman has been a Director of the Company since May 1995. He was President of the Kansas City Royals Baseball Club from 1992 to 2000. He was President of the Kauffman Foundation from 1985 to 1990 and Chairman of its Finance and Investment Committee from 1990 to 1999. Mr. Herman was the Executive Vice President and Chief Financial Officer of Marion Laboratories, Inc. from 1974 to 1990. He is a Trustee of Rensselaer Polytechnic Institute and the University of Chicago Graduate School of Business. Mr. Herman is presently a Director of Santarus, Inc. and Senomyx, Inc.

MEETINGS OF THE BOARD AND COMMITTEES

The Board has established Audit, Compensation and Nominating, Governance & Public Policy Committees. The Board has adopted a written charter for each of these Committees. The full text of each charter and the Company’s Corporate Governance Guidelines are available on the Company’s website located at www.cerner.com. The Board does not have an Executive Committee. During 2007, the Board held four regular meetings, the Audit Committee held 13 meetings, the Compensation Committee held two meetings and the Nominating, Governance & Public Policy Committee held two meetings. Each Director attended at least 75% of the total meetings of the Board and the Board committees on which the Director served during the fiscal year.

The Board has determined that all of the members of each of the Board’s three standing committees are independent as defined under the rules of The NASDAQ Stock Market, including, in the case of all members of the Audit Committee, the additional independence requirements of Rule 10A-3 under the Exchange Act. Under applicable NASDAQ rules, a Director of the Company will only qualify as an “independent director” if, in the opinion of the Board, that person does not have a relationship which would interfere with the exercise of independent judgment in carrying out the responsibilities of a Director. The Board has determined that none of the following Directors has a relationship which would interfere with the exercise of independent judgment in carrying out the responsibilities of a Director and that each of these Directors is an “independent director” as defined under Rule 4200(a)(15) of The NASDAQ Stock Market Marketplace Rules: Gerald E. Bisbee, Jr., Ph.D.; John C. Danforth; Nancy-Ann DeParle; Michael E. Herman; William B. Neaves, Ph.D.; and, William D. Zollars.

Pursuant to the Company’s Corporate Governance Guidelines, all Directors who are up for election are expected to attend the Annual Shareholders’ Meeting. All other Directors, barring unforeseen circumstances, are expected to attend the Annual Shareholders’ Meeting as well. All of our current Directors, including the Directors up for reelection this year, attended the 2007 Annual Shareholders’ Meeting.

The independent Directors generally hold executive sessions at each regularly scheduled Board meeting without management present and may hold additional executive sessions as they determine appropriate.

COMMITTEES OF THE BOARD

Audit Committee

The Audit Committee assists the Board in fulfilling its responsibilities with respect to our accounting and financial reporting practices, and in addressing the scope and expense of audit and related services provided by our independent public accounting firm. The Audit Committee has the authority to obtain advice and assistance from, and receive appropriate funding from the Company for, outside legal, accounting or other advisors as the Audit Committee deems necessary to carry out its duties. The Board has determined that the composition of the Audit Committee, the attributes of its members and the responsibilities of the Audit Committee, as reflected in its charter, are in accordance with applicable SEC rules and The NASDAQ Stock Market Marketplace Rules for audit committees. In particular, all Audit Committee members possess the required level of financial literacy, at least one member of the Audit Committee meets the current standard of requisite financial management expertise and the Board has determined that Gerald E. Bisbee, Jr., Ph.D., the Chairperson of the Audit Committee, is an “audit committee financial expert” as defined in Item 401(h) of Regulation S-K of the SEC.

Compensation Committee

The Compensation Committee’s primary responsibilities are to review and approve our compensation policies and practices, establish compensation for Directors, evaluate our Chief Executive Officer’s performance and establish compensation accordingly, review and approve the total compensation of our named executive officers, review and approve executive Performance-Based Compensation Plan targets and earned payouts and equity stock grants to our Section 16 insiders and adopt and approve major changes in our benefit plans and compensation philosophy.

The Compensation Committee of the Board of Directors is comprised of six Directors. Each of the members of the Compensation Committee are “independent directors” as defined by the NASDAQ Stock Market Marketplace Rules applicable to issuers such as the Company that have shares quoted on The NASDAQ Global Select Market. The

independence determination is made by the full Board of Directors each May based on all available facts and circumstances of each Director. The “independence” finding is also reviewed and confirmed by the Company’s Chief Legal Officer, Chief Financial Officer and outside counsel.

Compensation Committee membership is reviewed annually by the Company’s Nominating, Governance & Public Policy Committee, which then recommends to the full Board of Directors the Compensation Committee membership. Compensation Committee members are approved by the full Board of Directors each May.

The Compensation Committee meeting dates are reviewed and approved by the entire Compensation Committee, in an effort to ensure attendance; and Compensation Committee agendas are reviewed and approved prior to distribution to the rest of the Compensation Committee by the Compensation Committee Chairperson.

The Compensation Committee has a Charter that is available on the Company’s website located at: www.cerner.com under “About Cerner/Leadership/Compensation Committee.” The Charter is reviewed by the Compensation Committee annually in March and any recommended amendments to the Charter are considered for approval by the full Board of Directors. The Compensation Committee’s Charter was last revised in March 2005 and last reviewed, with no amendments recommended, by the Compensation Committee in March 2008.

The Compensation Committee’s scope of authority is as set forth in its charter. The Compensation Committee has further delegated its authority as follows:

	•		Stock Option Grant Subcommittee — this subcommittee of the Compensation Committee is appointed annually and consists of “outside directors” for purposes of Section 162(m) of the Internal Revenue Code and “non-employee directors” for purposes of 16(b) of the Securities Exchange Act. It has authority to review recommendations and approve equity grants and incentive-based compensation (targets, metrics and payments) of our executive officers,

	•		162(m) Subcommittee — this subcommittee of the Compensation Committee currently consists of the Chairperson of the Compensation Committee and has authority to: i) approve quarterly executive targets under the Company’s 162(m) Plan, ii) approve eligible Section 16 insiders for the executive targets, iii) approve the payment metrics for each Section 16 insider, iv) approve revisions to existing annual and quarterly executive targets, eligible Section 16 insiders and payment metrics and v) certify that an executive target has been satisfied, prior to payment by the Company to any executive officer. The 162(m) subcommittee reports to the full Compensation Committee at the next Compensation Committee meeting on any action approved by such subcommittee,

	•		Foundations Retirement Plan Administrative and Investment Committee — this committee currently consists of the Chief Financial Officer, Chief People Officer, Director of HR Compensation & Benefits Strategy and one other corporate executive named by the first three members. The committee has authority to: i) select, monitor and manage our 401(k) retirement plan’s (the “Plan”) third party administrator, record keeper, custodian and trustee, ii) monitor the Plan’s reporting to the IRS and Department of Labor, the Plan’s ERISA compliance, Plan audits and the payment of Plan expenses, iii) monitor and evaluate disclosures by the Plan to participants and beneficiaries, iv) ensure maintenance of fiduciary liability insurance coverage and the ERISA fidelity bond coverage, v) research and recommend Plan amendments, vi) adopt, review and carry-out investment policies and objectives for the Plan, vii) review and select the investment options offered under the Plan, viii) select and monitor the Plan’s investment managers and fund providers, ix) supervise, monitor and evaluate the performance of the investment options offered under the Plan, x) periodically review the Plan’s investment performance as a whole and xi) retain independent outside consultants.

Nominating. Governance & Public Policy Committee

The Nominating, Governance & Public Policy Committee provides assistance and recommendations to the Board, the Chairman and the Chief Executive Officer of the Company in the areas of: i) Board membership nomination, ii) committee membership selection and rotation practices, iii) evaluation of the overall effectiveness of the Board, iv) review and consideration of developments in corporate governance practices and v) review and consideration of current and emerging political, corporate citizenship and public policy issues that may affect our business operations, performance or public image. The Chairperson of the Nominating, Governance & Public Policy Committee presides at all executive session meetings of the independent Directors.

DIRECTOR COMPENSATION

From January 2007 through May 2007, non-employee Directors of the Company received an annual cash retainer of $25,000 paid in quarterly installments at each Board meeting and $2,500 for each Board meeting attended, plus reimbursement for expenses incurred in connection with attendance at Board meetings. During this same time period, the Chairperson of the Audit Committee received $2,000 for each Audit Committee meeting attended as Chairperson, the Chairperson of the Compensation Committee received $1,600 for each Compensation Committee meeting attended as Chairperson and the Chairperson of the Nominating, Governance & Public Policy Committee received $1,200 for each such Committee meeting attended as Chairperson. Additionally, each Committee member received $1,000 for each Committee meeting attended during this time period. All Director, Chairperson and Committee member fees were paid at 50% of such rates for attendance at telephonic Board and Committee meetings during this time period.

Effective and commencing June 2007, non-employee Directors received an annual cash retainer of $63,500. In addition, each Committee Chairperson received an additional annual cash retainer of varying amounts as follows: $19,500 for the Audit Chairperson, $8,250 for the Compensation Chairperson and $5,000 for the Nominating, Governance and Public Policy Chairperson. Additionally, each member of the Audit Committee (not including the Chairperson) received an additional annual cash retainer of $7,500. Effective June 2007, the Directors are no longer paid meeting fees. All cash retainers are paid in quarterly installments at each Board meeting; therefore, two installments were paid during 2007 based on this compensation scheme which became effective in June 2007. During 2007, the sole exception to the payments discussed above was with respect to Mr. Danforth who was entitled to receive $51,250 cash compensation based on the above described annual cash retainer and Board and Committee meetings fees; however, in lieu of cash, Mr. Danforth is compensated in the form of personal use of planes owned by or under contract to the Company, in accordance with our policies on personal use of such aircraft.

Each non-employee Director that was appointed or elected to the Board on or after May 2004, but prior to July 2006, received a grant of 2,500 shares of restricted stock upon such initial appointment/election that vested in equal amounts each year over a three-year term, provided the individual remained a Director of the Company. From July 2006 to May 2007, the initial equity grant value granted to newly-elected non-employee Directors was set at the number of shares with an approximate fair market value of $100,000 at the time of such grant, in order to avoid unintended compensation fluctuations based on stock price fluctuations, stock-splits, combinations or other changes in the number or type of the Company’s shares outstanding. As of June 2007, the initial equity grant value was reset to equal the annual grant value as discussed below, with a ratable vesting over three years. There were no Directors eligible to receive an initial appointment/election grant of shares of restricted stock in 2007.

Each non-employee Director that was elected or re-elected to the Board on or after May 2004, but prior to July 2006, also received a grant of 2,500 shares of restricted stock of the Company for each year of service on the Board. Beginning in July 2006, the equity component of the Board compensation package is based on a target dollar amount, not a fixed share amount (in order to avoid unintended compensation fluctuations based on stock price fluctuations, stock-splits, combination or other changes in the number or type of the Company’s shares outstanding). The target for the total annual Board compensation package for the May 2007 to May 2008 Board service period was set at $200,000 per year (with the actual amount varying from Board member to Board member depending on the committees they are members or chair of and the actual value of restricted shares when issued), which target was set to include an equity compensation component of approximately $129,000. In May 2007, pursuant to these Board equity compensation programs, 2,300 shares of restricted stock of the Company were granted to each of Dr. Bisbee,

Mr. Danforth, Ms. DeParle, Mr. Herman, Dr. Neaves and Mr. Zollars, respectively. These restricted stock grants will vest in May 2008 at the completion of the one year of Board services for which they were granted.

In March 2007, the Board approved Stock Ownership Guidelines that apply to the Company’s executive officers and the Board of Directors. The guidelines are further discussed in the Compensation Discussion and Analysis section. As of January 1, 2008, at the annual measurement date, all non-employee Directors were compliant with these guidelines.

The following table contains information regarding the compensation earned by non-employee Directors during 2007.


									Change in
									Pension
									Value and
									Nonqualified
	Fees						Non-Equity		Deferred		All Other
	Earned or		Stock		Option		Incentive Plan		Compensa-		Compensa-
	Paid in		Awards		Awards		Compensation		tion Earnings		tion
Name	Cash ($)		($) (1)		($) (2)		($)		($)		($) (3)		Total ($)
Gerald E. Bisbee, Jr., Ph.D.		69,000		137,551		—		—		—		—		206,551
John C. Danforth		—		154,948		—		—		—		41,406		196,354
Nancy-Ann DeParle		57,500		137,551		—		—		—		—		195,051
Michael E. Herman		54,975		137,551		—		—		—		—		192,526
William B. Neaves, Ph.D.		61,700		137,551		—		—		—		—		199,251
William D. Zollars		57,000		165,912		—		—		—		—		222,912


(1)		These amounts reflect the dollar amount recognized for financial statement reporting purposes for the fiscal year ended December 29, 2007, in accordance with FAS 123R of restricted stock awards and thus may include amounts from awards granted in and prior to 2007. As of December 29, 2007, each Director had the following number of restricted stock awards outstanding: Gerald E. Bisbee, 2,300; John C. Danforth, 3,968; Nancy-Ann DeParle, 2,300; Michael E. Herman, 2,300; William B. Neaves, 2,300; and, William D. Zollars, 3,968.

(2)		As of December 29, 2007, each Director had the following number of stock options outstanding: Gerald E. Bisbee, 32,000; John C. Danforth, 0; Nancy-Ann DeParle, 13,300; Michael E. Herman, 47,000; William B. Neaves, 40,000; and, William D. Zollars, 0.

(3)		During 2007, Mr. Danforth was entitled to receive $51,250 cash compensation based on the above described annual cash retainer and Board and Committee meetings fees; however, in lieu of cash, Mr. Danforth is compensated in the form of personal use of planes owned by or under contract to the Company, in accordance with our policies on personal use of such aircraft. The amount reported represents the value of Mr. Danforth’s personal use of the Company aircraft during 2007.

AUDIT COMMITTEE REPORT

Notwithstanding anything to the contrary set forth in any of the Company’s filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, the following report of the Audit Committee shall not be incorporated by reference into any such filings and shall not otherwise be deemed to be soliciting material or filed under such Acts.

The Audit Committee of the Company is currently composed of four independent members of the Board of Directors (all of whom have been determined by the Board to meet the independence requirements of the SEC and The NASDAQ Stock Market) and operates under a written charter adopted by the Board of Directors. The Audit Committee appoints and retains the Company’s independent registered public accounting firm. The selection is subsequently submitted to the shareholders of the Company for ratification.

Management is responsible for the Company’s internal controls and the financial reporting process. The independent registered public accounting firm, KPMG LLP, is responsible for performing an independent audit of the Company’s consolidated financial statements and issuing an opinion on the conformity of those audited consolidated financial statements with U. S. generally accepted accounting principles and on the effectiveness of the Company’s internal

control over financial reporting. The Audit Committee’s responsibility is to monitor and oversee these processes and to report to the Board of Directors on its findings.

In this context, the Audit Committee has met and held discussions with management and the independent registered public accounting firm. Management represented to the Audit Committee that the Company’s consolidated financial statements were prepared in accordance with U.S. generally accepted accounting principles, and the Audit Committee has reviewed and discussed the consolidated financial statements with management and the independent registered public accounting firm. The Audit Committee discussed with the independent registered public accounting firm matters required to be discussed by Statement on Auditing Standards No. 61 (Communications with Audit Committees).

The Company’s independent registered public accounting firm also provided to the Audit Committee the written disclosures and letter required by Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees), and the Audit Committee discussed with the independent registered public accounting firm that firm’s independence.

Based upon the Audit Committee’s discussion with management and the independent registered public accounting firm and the Audit Committee’s review of the representation of management and the report of the independent registered public accounting firm to the Audit Committee, the Audit Committee recommended that the Board of Directors include the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended December 29, 2007.

Members of the Audit Committee:
Gerald E. Bisbee, Jr., Ph.D.
Nancy-Ann DeParle
William B. Neaves, Ph.D.
William D. Zollars

Guidelines of Cerner Corporation’s Audit Committee
for Pre-Approval of Independent Auditor Services

The Audit Committee has adopted the following guidelines regarding the engagement of our independent registered public accounting firm to perform services for the Company:

For audit services (including statutory audit engagements as required under local country laws) and audit-related services, the independent auditor will provide the Audit Committee with an engagement letter during the first quarter of each year outlining the scope of audit and audit-related services proposed to be performed during the fiscal year. If agreed to by the Audit Committee, this engagement letter will be formally accepted by the Audit Committee at either its March or May Audit Committee meeting. The Audit Committee will approve, if necessary, any changes in the terms, conditions and fees resulting from changes in audit scope, Company structure or other matters.

The independent registered public accounting firm will submit to the Audit Committee for approval an audit services fee proposal with the engagement letter.

For any permissible non-audit services, the independent registered public accounting firm will provide the Audit Committee with a detailed scope of service description and fee range. Each non-audit service must be separately pre-approved by the Audit Committee. Our management and the independent registered public accounting firm will each confirm to the Audit Committee that any non-audit services for which pre-approval is requested are permissible under all applicable legal requirements.

To ensure prompt handling of unexpected matters, the Audit Committee delegates to the Chairperson of the Audit Committee the authority to amend or modify the scope of pre-approved permissible audit, audit-related or non-audit services and the fees related thereto. Upon receiving an unforeseen request for audit, audit-related or non-audit services or a change in the fee range, the independent registered public accounting firm will advise our management;

our management will request pre-approval for such change in audit, audit-related or non-audit services or fees from the Chairperson of the Audit Committee. The Audit Committee Chairperson will report on all action taken with respect to pre-approval of audit, audit-related or non-audit services and fees to the Audit Committee at the next Audit Committee meeting. With respect to any such pre-approval of non-audit services, our management and the independent registered public accounting firm will each confirm to the Audit Committee Chairperson that such non-audit services are permissible under all applicable legal requirements.

With respect to each proposed pre-approved service, the independent registered public accounting firm will provide sufficient detail in the description to ensure that the Audit Committee (or Chairperson, as applicable) knows precisely what services it is being asked to pre-approve so that it can make a well-reasoned assessment of the impact of the service on the registered public accounting firm’s independence.

The independent registered public accounting firm must ensure that all audit, audit-related and non-audit services provided to the Company have been approved by the Audit Committee.

COMPENSATION COMMITTEE REPORT

Notwithstanding anything to the contrary set forth in any of the Company’s filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, the following report of the Compensation Committee shall not be incorporated by reference into any such filings and shall not otherwise be deemed to be soliciting material or filed under such Acts.

The Compensation Committee reviewed and discussed with management the Compensation Discussion and Analysis section set forth below as required by Item 402(b) of Regulation S-K, and, based upon that review and discussion, recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.

Members of the Compensation Committee:
Gerald E. Bisbee, Jr., Ph.D.
John C. Danforth
Nancy-Ann DeParle
Michael E. Herman
William B. Neaves, Ph.D.
William D. Zollars

COMPENSATION DISCUSSION AND ANALYSIS

Compensation Strategy/Objectives

Our compensation strategy is to offer competitive compensation packages to attract, motivate and reward qualified associates who contribute significant value to Cerner. Our compensation program is designed to reward performance, such as attaining business and individual associate goals, business results, leadership, strong relationships with clients, and is not based on rewarding seniority. We believe that this strategy allows us to attract qualified candidates and maintain a reasonable business model. This compensation strategy is linked to our performance management philosophy that is designed to identify and reward associate performance through compensation. Our strategy is to target pay in aggregate at the median (50th percentile) within our peer group with top performers able to earn within the top quartile (75th percentile). We believe this strategy keeps us competitive in the marketplace.

Our human resources compensation team develops our peer group annually by analyzing companies whose annual revenue, total shareholder return (one year and three year), market capitalization and business model are similar to that of our Company. In addition, the companies we included in our 2007 peer group relative to comparing compensation were selected based on standard industrial classifications (SIC) and financial measures. The SIC’s used were computer programming services, prepackaged software, computer integrated systems design and computer processing, data preparation and processing services. The financial measures criteria related to market capitalization of $500 million to $10 billion and revenues of $300 million to $2 billion. These financial measures were used to obtain information on companies with market capitalization and revenues that were similar to ours. The companies included in our 2007 peer group were: Activision, Inc., Acxiom Corporation, Anteon International Corporation, Autodesk, Inc., Caci International Inc., ChoicePoint Inc., Cognos Corporation, Dendrite International, Inc., Eclipsys Corporation, Emdeon Corporation, Filenet Corporation, Intergraph Corporation, Keane, Inc., Kronos Incorporated, McAfee, Inc., Mentor Graphics Corporation, Microsystems, Inc., Parametric Technology Corporation, Perot Systems Corporation, Scientific Games Corporation, Sybase, Inc., Sykes Enterprises, Incorporated, Take-Two Interactive Software, Inc., THQ Inc. and Verisign Inc. Our peer group changed slightly from 2006 due to updating the financial measures criteria we use each year to compare to our growth and size.

At the beginning of each fiscal year, the Compensation Committee reviews our peer group and the history of all the elements of each executive officer’s total compensation, including base salary, performance-based cash incentive compensation and long-term incentive plan compensation, over each of the past three years in relation to the total compensation and compensation elements of the corresponding executive officers in our peer group. Typically, the Chief Executive Officer (CEO), along with our Chief People Officer (CPO), makes compensation recommendations to the Compensation Committee with respect to the executive officers who report to the CEO. The other executive officers do not participate in the setting of executive officer compensation. The Compensation Committee Chair reviews the peer group comparisons with the CPO and makes compensation recommendations to the Compensation Committee on the CEO. The Compensation Committee, after review and discussion of the items set forth above, makes the ultimate decision as to total compensation and compensation components for the Company’s CEO and reviews and approves the total compensation and compensation components for the other executive officers.

The Compensation Committee has authority to secure the services of advisers both internal and external to the Company. The Compensation Committee also has authority to retain outside consultants to review executive compensation, Board of Director compensation or perform any other analysis the Compensation Committee deems appropriate. Historically, the Compensation Committee has worked with our internal resources, such as the CPO and the human resources compensation team, to help it carry out its responsibilities. The Compensation Committee has also engaged Michael S. Kesner, Principal with Deloitte Consulting, an independent compensation consultant, to assist it in fulfilling its responsibility on an as-needed basis. Mr. Kesner is retained by the Compensation Committee and has worked with Cerner for approximately seven years. In 2007, Mr. Kesner was engaged to prepare an analysis of non-employee Board of Director compensation and comparison to our peer companies, advise the Compensation Committee regarding executive compensation programs generally and provide advice on trends in compensation.

Aligning Pay with Performance

During 2007, our management team continued practices established to closely link pay to performance. A quarterly performance review process was used to provide quarterly feedback to executives on their performance and attainment of Company goals. Under this program, executives whose performance was evaluated as being in the bottom 20% of all executives are not generally eligible for pay increases or additional stock option grants. In addition, such executive’s performance-based incentive compensation award, if earned, may be reduced or eliminated due to their performance.

Compensation Elements

Compensation for our executive officers includes: i) base salary, ii) performance-based cash incentive compensation and iii) long-term incentive plan compensation. To provide incentives to attain our business goals, a significant portion of executive compensation is at-risk and tied to individual and Company performance. We provide our executive officers with relatively limited perquisites, which the Compensation Committee believes are reasonable. Our process for allocating between short-term and long-term compensation is to ensure adequate base salary and cash bonus opportunity to attract and retain executives, while providing incentives to maximize long-term value for our Company and our shareholders. We determine the mix of base salary and performance-based cash incentive compensation based on balancing the needs of providing adequate guaranteed cash compensation while at the same time providing a meaningful incentive to motivate the executive to achieve the established performance targets. The cash compensation package for the NEOs effective April 1, 2007 ranged from 50% to 63% in base salary and 37% to 50% in targeted performance-based cash incentive compensation. Our total compensation package mix for the NEOs in 2007 ranged from 44% to 60% in cash compensation and 40% to 56% in non-cash compensation, which includes equity-related awards. We believe this formula is competitive within the marketplace, appropriate to fulfill our corporate objectives and addresses the goals outlined below under Long-Term Incentive Plan Compensation.

Base Salary. As set forth above, the Compensation Committee sets the salary level of our CEO and reviews peer group data and recommendations proposed by the CPO and the human resources compensation team prior to approving the salary of the Company’s potential NEOs (and reviews the recommendations for all executive officers) during the first quarter of each calendar year. Salary is based on the duties and responsibilities that each executive officer is expected to discharge during the current year and upon the executive officer’s performance during the prior year. We also perform external market comparisons for the executive officers, relative to industry-specific peers as disclosed above, based on individual job responsibility. This comparison data is used to help ensure that the proposed executive officer’s compensation is within reasonable market comparison ranges and in line with our compensation strategy as detailed above.

Performance-Based Cash Incentive Compensation. Our Performance-Based Compensation Plan is designed to provide a meaningful incentive on both a quarterly and annual basis to key associates and executive officers and to motivate them to assist in achieving short-term Company goals. Approximately 15% of our total associate base is eligible for some form of performance-based compensation. These associates are typically sales or executive level associates. Individual payments will vary, depending upon individual performance and, in some cases, business unit operational achievements. We grant such cash incentive bonuses pursuant to a shareholder approved Performance-Based Compensation Plan.

The Performance-Based Compensation Plan is administered by the Compensation Committee, which establishes performance metrics, eligibility and range of incentive amounts. Under the general feature of the plan, for which our executive officers are not eligible, the performance metrics may vary from participant to participant. Adjustments to the performance metrics may be made during the year as appropriate, for example, to take into account unusual or unanticipated Company or industry-wide developments. Final determination of the amounts to be paid to a participant under the general feature of the plan may also be adjusted upward or downward depending upon subjective evaluations by the participant’s executive or manager.

Performance targets are initially developed and recommended by management through our annual financial planning process during the last quarter of the preceding year. The Compensation Committee reviews the performance targets proposed by management for the executive officers to ensure they reflect appropriate business growth and return to our shareholders.

All of our executive officers are eligible to participate under the executive feature of the Performance-Based Compensation Plan. We offer our executive officers participation under the executive feature, because payments made to executive officers under the executive feature qualify for deducibility under Section 162(m) of the Internal Revenue Code. A subcommittee, comprised solely of outside directors as defined under Section 162(m) (the “162(m) Subcommittee”), of the Compensation Committee establishes the targets prior to or at the beginning of the performance period. The measurement of the achievement of such targets can be, and are, determined under pre-established objective formulas. The 162(m) Subcommittee may select metrics such as earnings per share, operating margins, contract margins or other metrics specifically permitted by the executive feature of the plan. The 162(m) Subcommittee selects metrics which it believes will help drive business growth and return to our shareholders while providing a meaningful incentive on both a quarterly and annual basis to the participants. Once established, the metrics or targets under the executive feature of the plan may not generally be changed. No changes were made to the established targets during 2007. Bonuses awarded to executive officers under the executive feature of the plan may only be adjusted downward, based upon a subjective analysis of the executive officer’s overall performance, from the maximum bonus amount available to such executive officer. The maximum bonus available is 140% of the targeted bonus amount based on the highest payout level of the performance metric plus 25% of the targeted bonus amount based on the executive officer’s individual performance.

The 162(m) Subcommittee approves annual and quarterly executive targets, approves eligible executive officers for the plan, approves the payment metrics for each executive officer, approves any revisions to existing annual and quarterly executive targets and determines whether one or more executive targets have been satisfied, prior to payment by the Company to any executive officer.

For the Company’s CEO, Mr. Patterson, the performance metric during 2007 consisted solely of earnings per share. During 2007, the performance metric for the other executive officers also consisted solely of earnings per share. Earnings per share was chosen as the sole performance metric for all executive officers during 2007 to help drive and ensure business growth and return to our shareholders while providing a meaningful incentive on both a quarterly and annual basis.

As a result of the Company’s 2007 performance relative to the attainment of these performance targets, we paid cash bonuses to our NEOs under the Performance-Based Compensation Plan. Aggregate incentives paid with respect to fiscal 2007 to our NEOs averaged 109% of the target incentive amount and 66% of the maximum cash incentive opportunity available. The following tables detail the payouts by performance plan metric for our NEOs in 2007 and the related performance plan metric attainment by quarter.


										% Earned
										Relative to			Maximum		% Earned of
				Results Relative		Target		Actual		Target			Cash		Maximum
		Performance		to Performance		Incentive		Amount		Incentive			Incentive		Cash Incentive
NEO	Performance Metric	Plan Target *		Plan Target *		Amount		Earned		Amount			Opportunity		Opportunity
Patterson.Neal	Earnings Per Share	$	1.70	$	1.74		891,250		971,200		109	%		1,470,000		66	%
Naughton,Marc	Earnings Per Share	$	1.70	$	1.74		200,000		218,000		109	%		330,000		66	%
Devanny, Trace	Earnings Per Share	$	1.70	$	1.74		393,750		429,000		109	%		650,000		66	%
Townsend,Jeff	Earnings Per Share	$	1.70	$	1.74		318,750		347,250		109	%		530,000		66	%
Valentine, Mike	Earnings Per Share	$	1.70	$	1.74		287,500		313,000		109	%		474,375		66	%
Total of Named Executive Officers							2,091,250		2,278,450		109	%		3,454,375		66	%


*		The plan targets and plan results in the above table reflect adjustments compared to results reported on a Generally Accepted Accounting Principles (GAAP) basis in our 2007 Form 10-K. These numbers have been adjusted to reflect performance against our Performance-Based Compensation Plan and exclude the impact of certain items that were not originally contemplated in setting plan targets, including the non-recurring items footnoted in Item 6 of our 2007 Form 10-K and a 1% lower tax rate than planned.


	Quarterly Performance Metric Summary (EPS)
Measurement								Payout			Quarterly
Period	Target(1)		Results		Attainment %			%			Weighting(2)
Q1	$	0.35	$	0.36		103	%		120	%		15	%
Q2 YTD	$	0.75	$	0.77		103	%		120	%		15	%
Q3 YTD	$	1.19	$	1.23		103	%		120	%		15	%
Q4 YTD	$	1.70	$	1.74		102	%		100	%		55	%
					Weighted Payout %				109	%


(1)		Target reflects the 100% performance payout level.

(2)		Quarterly weightings of the annual target incentive amounts.

For 2008, the Compensation Committee has approved the continued use of earnings per share as the sole performance metric for all executive officers. We believe this metric aligns well with our internal financial imperatives to expand operating margin and grow bottom line earnings, and the Compensation Committee believes this is the best performance metric to help drive and ensure business growth and return to our shareholders while providing a meaningful incentive on both a quarterly and annual basis to our executive officers. The 2008 performance targets have been set based on the financial plan approved annually by the Board of Directors, which historically reflects targeted levels of earnings growth between 20% and 30%. The 2008 bonus opportunity for the NEOs can range between 0% and 140% of the targeted bonus amount depending on the level of performance achieved in 2008. The earnings per share target set at each level of payout, as a percentage of the performance target, is consistent with prior years.

In 2007, the Compensation Committee approved new “claw back” language to our Performance-Based Compensation Plan. The 2008 performance plan agreements for our executive officers contain language stating that in the event we implement a Mandatory Restatement (as defined in the Performance-Based Compensation Plan), which restatement relates to the 2008 fiscal year, some or all of any amounts paid as an incentive payment earned by the executive officer under the Performance-Based Compensation Plan and related to such restated period(s) will be recoverable and must be repaid, in most cases, within 90 days of such restatement(s). The amount to be repaid will be the amount by which the incentive compensation paid exceeds the amount that would have been paid based on the financial results reported in the restated financial statement(s). Additionally, new in 2008 incentive plan agreements, all participants (including our executive officers) will be required to repay all earned incentive compensation payments if they are individually found by Cerner’s Board of Directors to have engaged in fraud or misconduct that caused or partially caused the need for a Mandatory Restatement.

Long-Term Incentive Plan Compensation. Our Long-Term Incentive Plans are designed to drive long-term shareholder value and retain valuable associates and executives by: i) positioning us competitively as an employer, ii) creating an incentive for associates to contribute to our sustained, long-term growth, iii) creating a mutuality of interest between our associates and shareholders and iv) providing financial incentives for associates. The program encourages associate stock ownership in an effort to align associates’ interests with shareholders’, thereby encouraging extraordinary effort by our associates. Our awards under Long-Term Incentive Plans have historically been in the form of stock options.

The Compensation Committee approves an annual aggregate value target for all eligible associates excluding executive officers and members of the Board. The Compensation Committee also approves specific grant levels for executive officers and members of the Board on an annual basis. Stock option grants are typically made to an executive upon commencement of employment with the Company or upon an associate’s promotion to an executive role. Executives are eligible for additional stock option grants on an annual basis as individual and Company performance warrants. Grants are also made to the top 20% performers below the executive level based upon individual achievements. The Compensation Committee believes that stock option grants continue to provide the best value and incentive for our associates and executives given our historical stock performance, the familiarity of this type of compensation to associates and since exercises have historically generated value to associates in excess

of the expense to the Company. We have issued restricted stock to our non-employee Directors, as set forth more fully in the Director Compensation disclosure above. Additionally, during 2007, the Compensation Committee approved a restricted stock grant to one of our executive officers to compensate him upon his return from an expatriate assignment during which time he did not receive stock option grants. Our current Long-Term Incentive Plans also allow for the granting of stock appreciation rights, phantom stock and performance unit awards which, at the discretion of the Compensation Committee, may be payable in the form of common stock or cash.

In December 2007, the Board of Directors approved an updated Equity-based Grant Policy which outlines in writing the grant practices with respect to equity-based grants awarded under the Company’s Long-Term Incentive Plans. The amendments to this policy established new grant dates for some of our stock option programs to ensure grant dates would be outside of trading blackout periods. The Board of Directors, the Compensation Committee or an authorized sub-committee of the Compensation Committee approves: i) the equity grant type, ii) the grant date and iii) the number of shares of the annual performance review equity grants made to the Company’s executive officers. Grants of non-qualified stock options are made at an exercise price that is equal to the closing fair market price of our common stock on the date of grant. Under the Equity-based Grant Policy, the date of grant must be a date set at the time of grant approval, which date: a) shall be on or after the grant approval date, b) shall not be during a quarterly blackout period as defined in the Company’s trading policy and c) if the Board of Directors or the Compensation Committee is aware of any material, non-public information at the time it approves the grant, shall be a date that is at least two full trading days after the public disclosure of such material, non-public information. The size of the grant is based on the individual’s level of responsibility, the individual’s contributions to the achievement of the Company’s financial and strategic objectives, anticipated future contributions to the Company, market pay and for our executive officers, the amount, exercise price and term of options already held by the individual. Grants typically vest over a five-year term with 40% vesting at the end of the second year and 20% each year thereafter (this vesting schedule has been determined by the Board and is intended to promote long-term investment in Cerner stock) and expire 10 years from the date of grant.

In accordance with our overall compensation philosophy and view of appropriate total compensation, and, in particular, to further the long-term perspective that we believe is necessary for our future success, we granted stock option awards to our executive officers, including the CEO, in March 2007. Individual grants for executive officers were based on job responsibilities, performance during 2006 and contributions to the achievement of the Company’s financial and strategic objectives, anticipated future contributions to the Company, market pay and stock option wealth accumulation; all factors the Compensation Committee believes help ensure we are awarding such executives competitively and fairly. The Compensation Committee has approved similar stock option grants to our executive officers for 2008. These grants were approved on March 11, 2008 and granted on March 14, 2008.

Compensation of the Chief Executive Officer and other NEOs

The Compensation Committee determines compensation for the Chief Executive Officer (CEO) using the same criteria it uses for other executive officers. The Compensation Committee meets each year in executive session to evaluate the performance of the CEO and determine his appropriate compensation package including base salary, performance-based cash incentive compensation and long-term incentive compensation. We analyze the total compensation for our NEOs compared to the compensation of the corresponding executive officers in our peer group to ensure alignment with our strategy of paying in aggregate at the median (50^th percentile) within our peer group with top performers able to earn within the top quartile (75 percentile).

In March 2007, the Compensation Committee increased Mr. Patterson’s base salary and performance-based cash incentive compensation to approximate compensation amounts in the top quartile of the market within our peer group as a result of his strong performance during 2006. In connection with this increase, Mr. Patterson was also issued a stock option grant of 80,000 shares at the closing fair market value on March 9, 2007, the date of the grant. This grant was made to align his total compensation to be in the top quartile of the market within our peer group in recognition of the Company’s successes and Mr. Patterson’s strong performance and achievements in 2006. In particular, the Compensation Committee noted that the Company had achieved sustained long-term growth in backlog, revenue and earnings with 10 year compounded annual revenue and earnings growth in excess of 20%. The Compensation Committee also recognized that under Mr. Patterson’s leadership the Company had successfully expanded into the global market and had developed and was developing new solutions and services to enter markets in which the Company was not previously competing. The Compensation Committee also believed Mr. Patterson

was doing an excellent job of growing new leaders within the Company, delivering on objectives of continuing to develop client relationships and in making sure the Company and Mr. Patterson were both active and influential in healthcare policy matters.

Specifically in 2007, the Compensation Committee approved a base salary of $900,000 and performance-based cash incentive target opportunity of $900,000 (with a maximum performance-based cash incentive opportunity of $1,470,000) for Mr. Patterson effective April 1, 2007. During 2007, Mr. Patterson earned total cash compensation of $1,862,450 which included $891,250 in base salary and $971,200 in payments earned under the Company’s Performance-Based Compensation Plan. Mr. Patterson also earned a total of $106,593 in other compensation from: i) private use of the corporate jet ($96,581), ii) Company provided life insurance ($397), iii) 401(k) match ($5,115) and iv) the second tier 401(k) match ($4,500). Mr. Patterson earned 109% of the target incentive amount and 66% of the maximum cash incentive opportunity available to him under the Performance-Based Compensation Plan during 2007.

The Compensation Committee has set Mr. Patterson’s base salary for 2008 at $940,000, his performance-based cash incentive compensation target at $940,000 and the maximum performance-based cash incentive opportunity at $1,530,000. The Compensation Committee approved Mr. Patterson’s personal use of the corporate aircraft in 2008 up to a value of $100,000, with personal use exceeding such value being permitted pursuant to the terms and conditions of the Time Sharing Agreement entered into between Mr. Patterson and the Company, which requires Mr. Patterson to pay for such personal use. The Stock Option Subcommittee of the Compensation Committee also approved on March 11, 2008 a stock option grant to Mr. Patterson of 72,000 shares made on March 14, 2008. His 2008 base salary and performance-based incentive cash compensation became effective April 1, 2008.

The Compensation Committee has approved the 2008 compensation packages, effective April 1, 2008, of each of the NEOs, other than the CEO, as follows:

Marc G. Naughton — base salary of $375,000; performance-based cash incentive compensation target of $220,000; and, a stock option grant of 22,500 shares. Mr. Naughton’s 2008 maximum performance-based cash incentive opportunity has been set at $350,000.

Earl H. Devanny — base salary of $470,000; performance-based cash incentive compensation target of $430,000; and, a stock option grant of 15,000 shares. Mr. Devanny’s 2008 maximum performance-based cash incentive opportunity has been set at $700,000.

Jeffrey A. Townsend — base salary of $440,000; performance-based cash incentive compensation target of $370,000; and, a stock option grant of 30,000 shares. Mr. Townsend’s 2008 maximum performance-based cash incentive opportunity has been set at $590,000.

Michael G. Valentine — base salary of $380,000; performance-based cash incentive compensation target of $340,000; and, a stock option grant of 30,000 shares. Mr. Valentine’s 2008 maximum performance-based cash incentive opportunity has been set at $540,000.

The Stock Option Subcommittee of the Compensation Committee also approved the above described stock option grants to the NEOs on March 11, 2008 and the options were granted on March 14, 2008.

Internal Pay Equity

Our internal pay equity guidelines provide that the CEO’s total cash compensation shall not be more than three times that of the next highest total cash compensation. Our Board must approve any exception to these guidelines.

Stock Ownership Guidelines

In March 2007, our Board approved stock ownership guidelines. Under these guidelines, our non-employee Board members and every associate that is a vice-president or higher in rank, are required to have a certain level of share ownership in our Company. Ownership in our Company demonstrates a long-term commitment and ensures strong

alignment of interests of Directors and executives with the interests of shareholders. The stock ownership guidelines were made effective immediately, with future measurements completed on January 1^st of each year.


Ownership Percentage Requirement
Board of Directors and CEO	80	%
President and Executive Vice President	70	%
Senior Vice President	60	%
Vice President	50	%

Ownership Position Formula = Ownership Position (defined below) divided by Total Stock Options Granted (net of expired and stock option grants with terms greater than 15 years) + Restricted Stock Awards

The Ownership Position includes any shares fully owned, including: shares owned by spouse, dependent children or a trust, outstanding stock options (excluding stock option grants with terms greater than 15 years), fully vested shares held in the Company’s 401(k) plan, shares held in the Associate Stock Purchase Plan, non-vested restricted stock awards and shares held in the Company’s deferred compensation plan.

For employee Directors and executives, a reduced ownership requirement scale will be applied based on tenure, starting with 11 years of full-time service with the Company with a minimum ownership requirement of one-half of the Ownership Percentage Requirement noted above regardless of tenure. For non-employee Directors, a reduced ownership requirement scale will be applied based on years of service with the Board with a minimum ownership requirement of 5 times the annual cash retainer, regardless of tenure. The guidelines also include hardship and retirement provisions.

As of January 1, 2008, at the annual measurement date, one of the NEOs is not compliant with these guidelines. The guidelines allow any executive or Director who is not currently compliant to submit a plan to the CEO indicating how compliance will be achieved within a five year timeframe.

Retirement

We have a 401(k) retirement plan in which contributions are made by the Company to the executive officers on the same basis as to all other associates. We offer this plan as part of our overall benefits and compensation package to remain competitive in the market and retain talent. The Company makes matching contributions to the plan, on behalf of participants, in an amount equal to 33% of the first 6% of the participant’s salary contribution. The Company also makes a discretionary match to participants’ accounts deferring at least 2% of their base salary, based on attainment of established earnings per share targets for the year. This discretionary match was made during 2007.

Associate Stock Purchase Plan

We have an Associate Stock Purchase Plan where participants may elect to make contributions from 1% to 20% of eligible compensation to the plan, subject to annual limitations determined by the Internal Revenue Service. Participants may purchase Company Common Stock at a 15% discount on the last business day of the purchase period. Executive officers are allowed to participate except those who own an aggregate of 5% or more of the total outstanding shares of the Company stock.

Health and Welfare Benefits

We have medical, dental and vision plans in which contributions are made by the Company to the executive officers on the same basis as to all other associates. Also, the cost of these plans and opportunity for benefits thereunder are the same for the executive officers as for all other associates. We offer these plans as part of our overall benefits and compensation package to remain competitive in the market and retain talent.

Perquisites

We consider offering perquisites to our NEOs for purposes of helping them effectively use their limited personal time and in recognition that they are on call 24 hours a day, seven days a week.

To increase the number of client visits our key executives can make and to reduce the physical strain of their heavy travel schedules, we own and/or lease aircraft (“Corporate Aircraft”). In limited circumstances, the Corporate Aircraft is available for personal use by certain Cerner executives as approved by the Compensation Committee or executive management. Our Section 16 executives (including the NEOs) and Directors may use the Corporate Aircraft for personal use only if such personal use is pre-approved (with a pre-approved value) by the Compensation Committee. Personal use of the Corporate Aircraft by the NEOs or Directors over or in lieu of Compensation Committee approved value is prohibited unless such use is pursuant to a written Aircraft Time Sharing Agreement with the Company. Personal use of the Corporate Aircraft by Section 16 executives (excluding NEOs) over or in lieu of Compensation Committee approved value is permitted if the value of the personal use is imputed as income to the Section 16 executive. Business travel needs override all personal use requests.

During 2007, Neal Patterson’s personal use of our Corporate Aircraft was valued at $128,037 incremental cost to the Company. Pursuant to the Aircraft Time Sharing Agreement described below, Mr. Patterson paid the Company for the value of the Corporate Aircraft personal use in excess of $96,581 (comprised of the $90,000 the Compensation Committee approved for Mr. Patterson’s personal use in 2007 plus the carry-forward personal use value of $6,581 approved by the Compensation Committee, but not used, in 2006).

In 2008, Mr. Patterson and his family may use the Corporate Aircraft for personal use up to $100,000 in value, which allows Mr. Patterson to use his limited personal time effectively. In December 2006, we entered into an Aircraft Time Sharing Agreement with Mr. Patterson, which governs all personal use flights by Mr. Patterson that exceed the Compensation Committee approved personal use of the Corporate Aircraft. Mr. Patterson will pay us for the actual expenses of each specific flight, including the actual expense items of any “deadhead” flights. The Compensation Committee has not designated any other NEOs as eligible to use the Corporate Aircraft for personal use up to a pre-approved value, and no other NEOs have entered into an Aircraft Time Sharing Agreement with us for personal use of the Corporate Aircraft.

We do not pay any tax gross-ups with regard to the taxable income related to these perquisites.

Severance Arrangements

Because employment with Cerner is at-will, Cerner has no obligation to compensate any associate upon termination from his or her employment other than as may be provided in that associate’s Cerner Associate Employment Agreement or as specifically set forth in our Enhanced Severance Pay Plan, which was first approved in 2005. We recognize that business needs, an associate’s work performance or other reasons may require termination of employment. Because we value the contributions of our associates, we promote compensation tools that will create and maintain a productive and fulfilling work environment, which tools also help with our recruiting and retention efforts. Our Enhanced Severance Pay Plan is used to: show that we value our associates and that we are interested in helping to mitigate the financial hardship caused by business conditions or other factors necessitating a termination; help recruit and assure retention of valuable associate experience, skills, knowledge, and background; and, reinforce and encourage continued attention and dedication to duties without distraction arising from the possibility of a Change in Control.

Our Enhanced Severance Pay Plan, which applies to all of our U.S.-based permanent, full-time salaried associates, offers severance pay upon: i) certain termination without “Cause” events, which severance benefits will range from two weeks to 52 weeks (depending on the associate’s role and tenure) of such associate’s annual base salary and contingent upon the associate satisfying certain conditions, including the execution of a severance and release agreement, providing us a complete release of all employment related claims by the eligible associate, or ii) qualifying terminations or resignations for “Good Reason” following a Change in Control, which severance benefits will be paid at 1.5 times the calculated weekly severance eligibility based on role and tenure and will include both base salary and average cash bonus. Our Enhanced Severance Pay Plan was most recently updated in December 2007 to ensure that any payments paid out pursuant to the terms of the Enhanced Severance Pay Plan

would be compliant with final regulations promulgated in 2007 under Section 409A of the Internal Revenue Code of 1986 (“Section 409A”).

Two of our NEOs are entitled to severance payments other than as set forth in our Enhanced Severance Pay Plan; these are: i) Trace Devanny, our President, who has an agreement with us to receive severance, if he is terminated by the Company without Cause, for a period of two years and ii) Neal Patterson, our Chief Executive Officer, whose severance agreement with the Company is disclosed below in the “Employment Agreements & Potential Payments Under Termination and Change In Control” section.

Deductibility of Executive Compensation

Section 162(m) of the Internal Revenue Code generally disallows a federal income tax deduction to a public company for compensation over $1 million per fiscal year paid to a company’s chief executive officer and its four other most highly compensated executive officers serving at the end of that year. Not subject to the deductibility limit, however, is compensation that qualifies as “performance-based” compensation. Our objective is to maximize the deductibility of compensation under Section 162(m) to the extent doing so is reasonable and consistent with the Company’s strategies and goals. Gains on exercises of stock options awarded under our shareholder approved Long-Term Incentive Plans and payments under our shareholder approved Performance-Based Compensation Plan are considered to be “performance-based” compensation not subject to the Section 162(m) deductibility limit. The Compensation Committee may from time to time approve compensation that is not deductible under Section 162(m).

Accounting for Stock-Based Compensation

Beginning on January 1, 2006, the Company began accounting for Long-Term Incentive Plan Compensation in accordance with the requirements of FASB Statement 123(R).

Employment Agreements

Employment agreements entered into with our associates primarily serve to: i) create an “at-will” employment relationship, ii) assign to us any intellectual property rights the associate may otherwise have to any discoveries, inventions or improvements related to our business made while in our employ or within one year thereafter and iii) provide for restrictive covenants the associate has to Cerner during and after employment with Cerner, including: confidentiality, noncompete and nonsolicit obligations. Such employment agreements help ensure protection of our intellectual property, client base and associates. We enter into employment agreements with all of our associates, including all of the NEOs. Refer to “Employment Agreements & Potential Payments Under Termination or Change In Control” section of this Proxy Statement for further details.

SUMMARY COMPENSATION TABLE

The following table sets forth information regarding compensation earned by our Chief Executive Officer, our Chief Financial Officer and three other most highly compensated executive officers for the fiscal year ended December 29, 2007.


											Change in
											Pension Value
											and Nonqualified
											Deferred
Name and						Stock	Option		Non-Equity		Compensation		All Other
Principal		Salary		Bonus		Awards	Awards		Incentive Plan		Earnings		Compensation
Position	Year	($)		($)		($)	($)(1)		Compensation(2)		($)		($)(3)		Total ($)
Neal L. Patterson	2007		891,250		—	—		1,800,575		971,200		—		106,593		3,769,618

Chairman of the	2006		848,750		—	—		1,730,109		1,017,384		—		81,785		3,678,028
Board and Chief
Executive Officer

Marc G. Naughton	2007		330,000		—	—		295,718		218,000		—		9,879		853,597

Chief Financial	2006		293,750		—	—		258,157		232,190		—		9,586		793,683
Officer

Earl H. Devanny, III	2007		457,500		—	—		504,322		429,000		—		14,706		1,405,528

President	2006		442,500		—	—		535,146		442,033		—		13,549		1,433,228

Jeffrey A. Townsend	2007		422,500		—	—		416,761		347,250		—		9,951		1,196,462

Executive Vice	2006		381,250		—	—		404,688		303,608				9,653		1,099,199
President

Michael G. Valentine (4)	2007		337,500		—	—		334,133		313,000		—		14,539		999,172

Executive Vice
President


(1)		These amounts reflect the dollar amount recognized for financial statement reporting purposes for the fiscal year ended December 29, 2007, in accordance with FAS 123R of stock option grants pursuant to the Long-Term Incentive Plan and thus may include amounts from stock options granted in and prior to 2007. Refer to the Notes to the Consolidated Financial Statements included in the Annual Report on Form 10-K filed on February 27, 2008 for the relevant assumptions used to determine the valuation of our option awards.

(2)		Reflects payments made under the Company’s Performance-Based Compensation Plan as described under Compensation Elements in this Compensation Discussion & Analysis.

(3)		This column includes the aggregate incremental cost to the Company of providing personal benefits to the NEOs. The personal benefits in this column include personal use of company aircraft for Mr. Patterson in the amount of $96,581 in 2007. This column also includes our matching contributions (both fixed and discretionary) to the NEO’s account pursuant to the Cerner Corporation 401(k) Retirement Plan, premiums paid by us on group term life insurance and the expense associated with the discount on common stock purchases under our Associate Stock Purchase Plan.

(4)		2007 information only is reported for Michael G. Valentine since he was not an NEO in 2006.

GRANTS OF PLAN-BASED AWARDS

The following table reflects estimated possible payouts under non-equity incentive plan awards and the number, exercise price and grant date fair value of option awards made to the NEOs in 2007. The Company’s non-equity incentive awards are granted to participants of our Performance-Based Compensation Plan based upon pre-established performance targets set annually by the Compensation Committee and the 162(m) Subcommittee. For more detailed information regarding our Performance-Based Compensation Plan, see “Compensation Elements — Performance-Based Cash Incentive Compensation” in the Compensation Discussion and Analysis above.

All Other

Option

Grant

All Other Stock

Awards:

Exercise

Date Fair

Estimated Possible Future

Estimated Future Payouts

Awards:

Number of

or Base

Value of

Payouts Under Non-Equity

Under Equity Incentive Plan

Number of

Securities

Price of

Stock and

Incentive Plan Awards

Awards

Shares of Stock

Underlying

Option

Grant

Threshold

Target

Maximum

Threshold

Target

Maximum

or Units(#)

Options (#)

Awards

Name

Date

($) (1)

($)

($) (2)

(#)

($/Sh) (3)

($) (4)

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

Neal L. Patterson

3/9/2007

668,438

891,250

1,470,000

—

80,000

53.81

2,328,792

Marc G. Naughton

3/9/2007

150,000

200,000

330,000

—

20,000

53.81

582,198

Earl H. Devanny, III

3/9/2007

295,313

393,750

650,000

—

20,000

53.81

582,198

Jeffrey A. Townsend

3/9/2007

239,063

318,750

530,000

—

25,000

53.81

727,748

Michael G. Valentine

3/9/2007

215,625

287,500

474,375

—

25,000

53.81

727,748


(1)		These amounts represent the lowest level of payouts, if any payout is triggered, for each metric under the Performance-Based Compensation Plan.

(2)		These amounts reflect the maximum available under the Performance-Based Compensation Plan. There is a further limit on the maximum payout relative to Section 162(m) of the Internal Revenue Code. This maximum is set at 200% of Neal Patterson’s base salary and 175% of the other executive officer’s base salary.

(3)		The exercise price was equal to the closing fair market value of our Common Stock on the date of grant.

(4)		Refer to the Notes to the Consolidated Financial Statements included in the Annual Report on Form 10-K filed on February 27, 2008 for the relevant assumptions used to determine the valuation of our option awards.

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END

The following table provides information regarding outstanding awards to the NEOs that have been granted but not vested or exercised.


	Option Awards
	Number
	of		Number of Securities
	Securities Underlying		Underlying Unexercised
	Unexercised Options		Options		Equity Incentive Plan Awards: Number of		Option		Option
	(#)		(#)		Securities Underlying Unexercised Unearned		Exercise Price		Expiration
Name	Exercisable		Unexercisable		Options (#)		($)		Date
Neal L. Patterson		75,000		—		—		21.65		6/14/2011	⁽¹⁾
		50,000		—				23.12		4/5/2012	⁽¹⁾
		40,000		10,000				11.30		6/12/2013	⁽¹⁾
		36,000		24,000				20.99		6/3/2014	⁽¹⁾
		32,000		48,000				31.41		6/3/2015	⁽¹⁾
		33,600		50,400				41.13		9/16/2015	⁽¹⁾
		—		100,000				43.51		3/9/2016	⁽¹⁾
		—		80,000				53.81		3/9/2017	⁽¹⁾
		590,000		—				14.81		6/28/2020	⁽²⁾

Marc G. Naughton		10,000		—		—		14.13		5/22/2008	⁽⁶⁾
		1,000		—				8.52		5/5/2009	⁽⁵⁾
		10,000		—				21.65		6/14/2011	⁽¹⁾
		20,000		—				23.12		4/5/2012	⁽¹⁾
		2,400		1,600				20.99		6/3/2014	⁽¹⁾
		10,000		15,000				31.41		6/3/2015	⁽¹⁾
		—		20,000				43.51		3/9/2016	⁽¹⁾
		—		20,000				53.81		3/9/2017	⁽¹⁾
		20,584		—				7.50		2/24/2022	⁽²⁾

Earl H. Devanny, III		50,000		—		—		21.65		6/14/2011	⁽¹⁾
		18,000		—				7.75		8/5/2011	⁽⁷⁾
		24,000		6,000				11.30		6/12/2013	⁽¹⁾
		50,000		50,000				23.12		4/5/2014	⁽³⁾
		4,800		3,200				20.99		6/3/2014	⁽¹⁾
		14,000		21,000				31.41		6/3/2015	⁽¹⁾
		—		25,000				43.51		3/9/2016	⁽¹⁾
		—		20,000				53.81		3/9/2017	⁽¹⁾

Jeffrey A. Townsend		15,060		3,340		—		12.50		6/1/2010	⁽³⁾
		16,700		—				12.00		6/5/2010	⁽¹⁾
		6,000		4,000				9.34		6/14/2011	⁽³⁾
		20,000		—				21.65		6/14/2011	⁽¹⁾
		20,000		—				23.12		4/5/2012	⁽¹⁾
		2,000		—				10.50		7/3/2012	⁽⁴⁾
		8,972		2,108				12.00		2/10/2013	⁽⁴⁾
		8,000		2,000				11.30		6/12/2013	⁽¹⁾
		8,000		2,000				18.04		9/4/2013	⁽¹⁾
		14,400		9,600				20.99		6/3/2014	⁽¹⁾
		12,000		18,000				31.41		6/3/2015	⁽¹⁾
		—		25,000				43.51		3/9/2016	⁽¹⁾
		—		25,000				53.81		3/9/2017	⁽¹⁾
		4,916		—				7.50		2/24/2022	⁽²⁾

Michael G. Valentine		7,800		2,600		—		11.63		12/3/2010	⁽³⁾
		1,600		—				21.65		6/14/2011	⁽¹⁾
		2,400		2,400				7.75		8/5/2011	⁽³⁾
		8,000		—				23.12		4/5/2012	⁽¹⁾
		4,000		2,000				11.30		6/12/2013	⁽¹⁾
		12,000		8,000				20.99		6/3/2014	⁽¹⁾
		8,000		12,000				31.41		6/3/2015	⁽¹⁾
		—		20,000				43.51		3/9/2016	⁽¹⁾
		—		25,000				53.81		3/9/2017	⁽¹⁾


(1)		Option vests over a five-year period with a 40% vest increment two years from date of grant and 20% vest increments for each of the next three years. Option expires 10 years from date of grant.

(2)		Option vests over a 10-year period with 10% vest increments for each of the 10 years from date of grant. Option expires 25 years from date of grant.

(3)		Option vests over a 10-year period with 10% vest increments for each of the 10 years from date of grant. Option expires 12 years from date of grant.

(4)		Option vests over a 10-year period with 10% vest increments for each of the 10 years from date of grant. Option expires 15 years from date of grant.

(5)		Option vests over a five-year period with 20% vest increments for each of the five years from date of grant. Option expires 10 years from date of grant.

(6)		Option vests 100% when performance metric was met. Option expires 10 years from date of grant.

(7)		Option vests over a nine-year period with the following vest increments from date of grant: 16%, 12.5%, 12.5%, 10%, 10%, 10%, 10%, 10% and 9%. Option expires 12 years from date of grant.

OPTION EXERCISES

The following table provides information regarding option exercises by our named executive officers during 2007.


	Option Awards				Stock Awards
	Number of				Number of
	Shares				Shares
	Acquired		Value Realized		Acquired		Value Realized
	on Exercise		on Exercise		on Vesting		on Vesting
Name	(#)		($)(1)		(#)		($)
Neal L. Patterson		—		—		—		—

Marg G. Naughton		41,408		1,962,708		—		—

Earl H. Devanny, III		20,000		840,521		—		—

Jeffrey A. Townsend		15,000		793,548		—		—

Michael G. Valentine		—		—		—		—


(1)		Represents the difference between the exercise price and the fair market value of our common stock on the date of Exercise.

EMPLOYMENT AGREEMENTS &
POTENTIAL PAYMENTS UNDER TERMINATION OR CHANGE IN CONTROL

Employment Agreements

We enter into employment agreements with all of our associates, including all of the NEOs. We entered into an updated employment agreement, dated January 1, 2008, with Neal Patterson, our Chairman of the Board and Chief Executive Officer. This updated employment agreement was amended from the November 10, 2005 version: i) to bring severance payments made pursuant to the terms of the agreement into compliance with Section 409A and ii) to add language that will reduce severance payments that are classified as a “parachute payment” under Section 280G of the Internal Revenue Code to the maximum amount allowable before the parachute penalties are triggered unless, even with the imposition of the 20% excise tax on Mr. Patterson, he would receive a larger benefit than he would it his “parachute payments” were reduced. This amendment was made to mutually benefit both parties without taking any potential benefit away from Mr. Patterson or exposing Cerner to any additional payment obligations. The material terms of Mr. Patterson’s employment agreement provide for: a) at-will employment, b) an annual base salary, specified use of the Company’s airplane and a potential bonus as determined annually by the Board, c) severance payments and benefits upon certain termination events, as discussed in detail below, d) an assignment provision wherein Mr. Patterson will assign all discoveries, inventions or improvements related to our business to us, e) a non-disclosure provision that survives in perpetuity, f) non-competition and non-solicitation provisions that are effective during the term of Mr. Patterson’s employment and for two years following termination of employment, for any reason, with the Company, and g) a general indemnification provision by Mr. Patterson and the Company.

We have entered into at-will employment agreements with each of our other NEOs. Under these agreements, each executive agrees not to compete with us during the executive’s employment with us and for at least two years thereafter; to protect our confidential business information; and, to assign to us any intellectual property rights he may otherwise have to any discoveries, inventions or improvements related to our business made while in our employ or within one year thereafter.

Our Enhanced Severance Pay Plan was amended in 2007 to conform with the final regulations of Section 409A. Our Enhance Severance Pay Plan, which applies to all of our U.S. based permanent, full-time salaried employees, offers severance pay upon: i) certain termination without cause events, which severance benefits will range from two weeks to 52 weeks (depending on the employee’s role and tenure), as set forth in the Severance Matrix below, of such employee’s annual base salary and contingent upon the employee satisfying certain conditions, including without limitation the execution of a severance and release agreement with us providing for a complete release of all employment related claims by the eligible employee, or ii) qualifying terminations or resignations for Good Reason following a Change in Control, which severance benefits will be paid at 1.5 times the calculated severance (based on role and tenure) as set forth below in the Severance Matrix, and will include both base salary and average cash bonus.

Severance Matrix

Role Level/

Level 1

Years of

(V.P.’s –

Level 1

Service

Cabinet

non-Cabinet)

(Directors)

Levels 2 and 3

Levels 4 and 5

Levels 6 and 7

>10 Years

52 weeks

32 weeks

24 weeks

16 weeks

12 weeks

8 weeks

5-10 Years

36 weeks

24 weeks

18 weeks

12 weeks

9 weeks

6 weeks

2-5 Years

24 weeks

16 weeks

12 weeks

8 weeks

6 weeks

4 weeks

0-2 Years

16 weeks

10 weeks

6 weeks

4 weeks

3 weeks

2 weeks

The amount of any severance benefits paid out under the Enhanced Severance Pay Plan is in lieu of, and not in addition to, any other severance an eligible associate may otherwise be entitled to receive from us, including under a Cerner Associate Employment Agreement or other document.

Two of our NEOs are entitled to severance payments other than as set forth in our Enhanced Severance Pay Plan. These are: i) Trace Devanny, our President, who has an agreement with us to receive two years’ severance if he is terminated by the Company without cause and ii) Neal Patterson, our Chief Executive Officer, whose severance agreement with the Company is disclosed immediately below.

Potential Payments Upon Termination or Change in Control

The following summaries set forth potential payments payable to our NEOs upon termination of employment or a Change in Control in the Company under their current employment agreements and our other compensation programs, including our Enhanced Severance Pay Plan. The Compensation Committee may in its discretion revise, amend or add to the benefits if it deems advisable.

Neal L. Patterson

Termination by us without Cause (prior to a Change in Control): If Mr. Patterson’s employment is terminated by us without Cause (as defined in his Employment Agreement), Mr. Patterson will be entitled to:

Severance Pay: i) three years’ base salary (based on his annual base salary at the time of the termination) (less normal tax and payroll deductions) and ii) three times the average annual cash bonus received during the prior three year period (less normal tax and payroll deductions). These severance payments will generally be payable pro rata during the three year severance term on Cerner’s regular paydays, other than amounts during the first six months that qualify as “excess severance payments” as defined under Section 409A (which amounts will be paid at a later date in accordance with the Employment Agreement).

Benefits: health benefits for a three-year period following the termination of employment.

Equity Awards: immediate vesting of all equity incentive awards granted to Mr. Patterson after the original date of his Employment Agreement, to the extent such grants would have vested based on the passage of time during the three year period following the date of Mr. Patterson’s termination without Cause had he not been terminated. Upon termination by us without Cause, Mr. Patterson will forfeit any equity awards granted prior to the date of his Employment Agreement, unless otherwise provided in the equity award agreement entered into with Mr. Patterson at the time of grant, except that he will generally have a period of time following termination of employment to exercise any vested options in accordance with the terms of each specific option agreement.

Termination by us without Cause or Resignation by Mr. Patterson for Good Reason (both upon or following a Change of Control): If there is a Change in Control of the Company (as defined in his Employment Agreement), and either: a) Mr. Patterson’s employment with us is terminated without Cause within 12 months following the date the Change in Control becomes effective, or b) Mr. Patterson resigns his employment with Good Reason (as defined in his Employment Agreement) within 12 months after the Change in Control becomes effective, then Mr. Patterson will be entitled to:

Severance Pay: i) three years’ base salary (based on his annual base salary at the time of the termination or resignation) (less normal tax and payroll deductions) and ii) three times the average annual cash bonus received during the prior three year period (less normal tax and payroll deductions). These severance payments will be payable either pro rata or in a lump sum payment depending on whether the Change in Control event meets the definition of change in control under Section 409A.

Benefits: health benefits for a three-year period following the termination or resignation.

Equity Awards: following the Change in Control, 50% of each equity incentive award granted to Mr. Patterson under any of our equity incentive plans after June 1, 2005 and prior to the date the Change in Control becomes effective that has not yet vested will become vested on the date the Change in Control becomes effective. The remaining 50% of each equity incentive award that has not yet vested will continue to vest according to its vesting schedule, unless Mr. Patterson’s employment is terminated without Cause or he resigns with Good Reason within 12 months following the date the Change in Control becomes effective, in which case 100% of all equity incentive awards made after June 1, 2005 will become fully vested upon the effective date of such termination or resignation. Upon termination by us without Cause, Mr. Patterson will forfeit any outstanding equity awards granted prior to June 1, 2005, unless otherwise provided in the award agreement entered into with Mr. Patterson at the time of grant, except that he will generally have a period of time following termination of employment to exercise any vested options in accordance with the terms of each specific option agreement. The Compensation Committee or Board, however, may decide to accelerate the vesting of any of Mr. Patterson’s options.

Termination by us for Cause or Resignation by Mr. Patterson (other than for Good Reason upon a Change in Control): In the event we terminate Mr. Patterson’s employment for Cause or if Mr. Patterson resigns his employment (other than for Good Reason within 12 months following a Change in Control), Mr. Patterson will be entitled to no further compensation or benefits under his Employment Agreement other than: unpaid salary and earned incentive pay in accordance with our policies.

Equity Awards: unless otherwise provided in the award agreement entered into with Mr. Patterson at the time of grant, upon termination for Cause (as defined in the award agreements) or resignation by Mr. Patterson (other than for Good Reason within 12 months following a Change in Control), Mr. Patterson will forfeit any outstanding unvested awards on the termination date, and he will generally have a period of time following termination of employment to exercise any vested options in accordance with the terms of each specific option agreement.

Termination upon Death or Disability: In the event Mr. Patterson’s employment is terminated as a result of his Disability (as defined in his Employment Agreement) or in the event of Mr. Patterson’s death, we will owe Mr. Patterson no further compensation under his Employment Agreement other than: unpaid salary and earned incentive pay in accordance with our policies.

Benefits: if Mr. Patterson’s employment is terminated as a result of his death, his estate is entitled to life insurance benefits under our group life insurance program equal to $500,000. In the event of accidental death and dismemberment, Mr. Patterson’s estate would receive an additional $500,000. In the event that Mr. Patterson died in a travel accident while on Cerner business, his estate would receive an additional $200,000.

Equity Awards: unless otherwise provided in the award agreement entered into with Mr. Patterson at the time of grant, upon termination due to Disability or death, Mr. Patterson will forfeit any outstanding awards, except that he or his estate will generally have a period of time following termination of employment to exercise any vested options in accordance with the terms of each specific option agreement. The Compensation Committee or Board, however, may decide to accelerate the vesting of any of Mr. Patterson’s options.

Assuming Mr. Patterson’s employment was terminated under each of these circumstances on December 29, 2007, such payments and benefits have an estimated value of:


						For Cause
				Termination		Termination or
				Without Cause or		Resignation
		Termination		Resignation for		(without Good
		Without Cause		Good Reason		Reason following
Name	Payment/Benefit	(prior to a CIC)		(following a CIC)(1)		a CIC)		Death(2)		Disability
Neal L. Patterson	Cash Severance	$	5,578,402	$	5,578,402		—		—		—

	Health Benefits Continuation(3)	$	55,064	$	55,064		—	$	500,000		—

	Value of Accelerated Equitv(4)(5)	$	1,306,560	$	2,173,610		—		—		—


1.		Assumes an effective Change in Control date of December 29, 2007.

2.		The value of death benefits includes the value of basic life insurance. In the event of accidental death and dismemberment, Mr. Patterson’s estate would receive an additional $500,000. In the event that Mr. Patterson died in a travel accident while on Cerner business, his estate would receive an additional $200,000.

3.		In the case of a termination without Cause or Resignation for Good Reason, this includes the cost of premiums for health, vision and dental benefits over a three year period, based on the rates in effect on January 1, 2008.

4.		The payments relating to stock options represent the value of unvested, accelerated stock options as of December 29, 2007, calculated by multiplying the number of accelerated options by the difference between the exercise price and the closing price of our Common Stock on December 28, 2007. Assumes Mr. Patterson’s employment is terminated without Cause or he resigns with Good Reason within 12 months following the date the Change in Control becomes effective.

5.		Does not include the value of Mr. Patterson’s vested options of $34,210,328 as of December 29, 2007 or options that would vest automatically upon a Change in Control even if Mr. Patterson’s employment continued (50% of unvested options granted after June 1, 2005).

Marc G. Naughton; Earl H. “Trace” Devanny, III; Jeffrey A. Townsend and Michael G. Valentine

Termination by us without Cause (with or without a Change in Control event) or Resignation (for Good Reason following a Change in Control event): If we terminate any one of the above NEO’s employment without cause (as defined in the employment agreement), each one will be entitled to:

Severance Pay: the equivalent of two weeks’ base salary (exclusive of commissions, advances against commissions, bonus and other non-salary compensation and benefits), except Mr. Devanny (who will be entitled to the equivalent of two years’ base salary, based on his annualized base salary amount at the time of the involuntary termination, less appropriate payroll deductions, which amounts are not payable should Mr. Devanny choose to accept other employment during the severance period), and Mr. Townsend (who does not have a severance pay provision in his employment agreement). In addition, if we terminate any one of the above NEO’s employment without Cause (as defined in our Enhanced Severance Pay Plan, see discussion above), with or without a Change in Control event, each one may be entitled to certain additional severance pay under our Enhanced Severance Pay Plan if he is found to be an Eligible Associate (as defined in the Enhanced Severance Pay Plan), which eligibility would entitle him to both non-Change in Control Severance and Change in Control Severance (both defined in the Severance Play Plan) and such amounts would be in lieu of and not in addition to the severance, if any, set forth in their employment agreement.

If any one of the above resigns for Good Reason upon a Change in Control event, he may be entitled to certain additional severance pay under our Enhanced Severance Pay Plan if he is found to be an Eligible Associate, which eligibility would entitle him to Change in Control Severance in such amounts as set forth in the Enhanced Severance Pay Plan.

Equity Awards: unless otherwise provided in the award agreement at the time of grant, upon termination by us without cause, the above NEOs will forfeit any outstanding awards except that they will generally have a period of time following termination of employment to exercise any vested options in accordance with the terms of each specific option agreement. Additionally, stock options issued after June 1, 2005 provide that upon termination of the NEO by us other than for Cause (as defined in the option agreement) or upon resignation for Good Reason (as defined in the option agreement) within 12 months following a Change in Control, all remaining unvested options shall vest immediately (at the time of the Change of Control; 50% of such unvested options would have vested upon the Change in Control under the terms of such option agreements).

Termination by us for Cause or upon Resignation (other than for Good Reason following a Change in Control event): If we terminate one of the above NEO’s employment for Cause (as defined in their employment agreements) or if one of the above NEOs resigns his employment (other than for Good Reason following a Change in Control event), he will be entitled no further compensation or benefits under his employment agreement other than: unpaid salary and earned incentive pay in accordance with our policies.

Equity Awards: unless otherwise provided in the award agreement at the time of grant, upon termination for Cause (as defined in the award agreements) or resignation (other than for Good Reason if addressed and defined in the option agreement), the above NEO will forfeit any outstanding unvested awards on the termination date, and he will generally have a period of time following termination of employment to exercise any vested options in accordance with the terms of each specific option agreement.

Termination upon Death or Disability: In the event one of the above NEO’s employment is terminated as a result of his disability or in the event of death, we will owe no further compensation under the employment agreement other than: unpaid salary and earned incentive pay in accordance with our policies.

Benefits: if employment is terminated as a result of death, the NEO’s estate is entitled to life insurance benefits under our group life insurance program equal to one year’s salary, with a cap of $500,000, based upon his salary at the time of death. In the event of accidental death and dismemberment, the NEO’s estate would receive an additional one year’s salary, with a cap of $500,000, based upon his salary at the time of death. In the event the NEO died in a travel accident while on Cerner business his estate would receive an additional $200,000.

Equity Awards: unless otherwise provided in the award agreement at the time of grant, upon termination due to Disability or death, the above NEO will forfeit any outstanding awards except that he or his estate will generally have a period of time following termination of employment to exercise any vested options in accordance with the terms of each specific option agreement.

Noncompete Payments: If any of the above NEOs (other that Mr. Devanny or Mr. Townsend) is unable to obtain employment within three months after termination of his employment due solely to the noncompete restrictions set forth in his employment agreement, the noncompete provisions will continue to be enforceable only so long as we make to him monthly payments, during the remaining noncompete period, equivalent on an annualized basis, to his average earnings during the last three years of his employment. Mr. Devanny’s severance payments under his employment agreement are in lieu of any noncompete payments that he might otherwise receive. Mr. Townsend’s employment agreement, while containing a noncompete provision, does not address severance pay or noncompete payments.

Assuming each of the four NEOs (excluding Mr. Patterson, see table above) employment was terminated under each set of circumstances set forth above on December 29, 2007; the following table provides information regarding the estimated value of all such payments and benefits.


				Termination		For Cause
				Without Cause or		Termination or
		Termination		Resignation for		Resignation (without
		Without Cause		Good Reason		Good Reason
Name	Benefit	(prior to a CIC)		(following a CIC)(1)		following a CIC)		Death(2)		Disability
Marc G. Naughton	Cash Severance	$	340,000	$	823,736		—		—		—

	Benefits		—				—	$	340,000		—

	Value of Accelerated
	Equity and
	Performance
	Awards(3) (4)		—	$	374,713		—				—

	Noncompete
	Payments(5)	$	886,257	$	886,257		—				—

Earl H. Devanny.III	Cash Severance	$	920,000	$	920,000-$1,355,982		—		—		—

	Benefits		—		—		—	$	460,000		—

	Value of Accelerated
	Equity and
	Performance
	Awards(3) (4)		—	$	488,413		—		—		—

	Noncompete
	Payments(5)		—		—		—		—		—

Jeffrey A. Townsend	Cash Severance	$	430,000	$	1,118,934		—		—		—

	Benefits		—		—		—	$	430,000		—

	Value of Accelerated
	Equity and
	Performance
	Awards(3) (4)		—		^$458,575		—		—

	Noncompete
	Payments(5)		—		—		—		—

Michael G. Valentine	Cash Severance	$	242,308	$	660,756		—		—		—

	Benefits		—		—		—	$	350,000		—

	Value of Accelerated
	Equity and
	Performance
	Awards(3) (4)		—	$	344,875		—		—		—

	Noncompete
	Payments(5)	$	1,027,118	$	1,027,118		—		—		—


1.		Assumes an effective Change in Control date of December 29, 2007. Mr. Devanny’s cash severance following a Change in Control would range from $920,000 if he is terminated without Cause to $1,355,982 if he resigns for Good Reason.

2.		The value of death benefits includes the value of basic life insurance. In the event of accidental death and dismemberment, each NEO’s estate would receive the value of one additional year’s salary based upon his salary at the time of death. In the event an NEO died in a travel accident while on Cerner business his estate would receive an additional $200,000.

3.		The payments relating to stock options represent the value of unvested, accelerated stock options as of December 29, 2007, calculated by multiplying the number of accelerated options by the difference between the exercise price and the closing price of our common stock on December 28, 2007. Assumes NEO’s employment is terminated without Cause or each resigns with Good Reason within 12 months following the date the Change in Control becomes effective.

4.		Does not include the value of the NEO’s vested options as of December 29, 2007, which would equal the following amounts: Marc G. Naughton, $2,912,673; Earl H. Devanny, III, $6,069,862; Jeffrey A. Townsend, $5,414,401; and, Michael G. Valentine, $1,644,877 or options that would vest automatically upon a Change in Control even if the NEO’s employment continued (50% of unvested options granted after June 1, 2005).

5.		Noncompete payments represent payments for months four to 21 per the terms of the employment agreement, assuming the executive officer is unable to obtain employment within three months after termination of his employment due solely to the noncompete restrictions set forth in his employment agreement. Mr. Devanny’s severance payments under his employment agreement are in lieu of any noncompete payments and Mr. Townsend’s employment agreement does not address noncompete payments.

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

None of our Directors is an executive officer of a public company of which a Company executive officer is a director. None of our non-employee Directors have an interest in a reportable transaction that would be required to be disclosed under the section in this Proxy Statement titled “Certain Transactions”. Both of our non-independent directors, Neal Patterson and Cliff Illig, have an interest in a reportable transaction as set forth under the section of this Proxy Statement titled “Certain Transactions”, and such transactions have been approved by the Board of Directors consisting of votes from only the disinterested Directors.

None of the Company’s Compensation Committee members (Gerald E. Bisbee, Jr., Ph.D., John C. Danforth, Nancy-Ann DeParle, Michael E. Herman, William B. Neaves, Ph.D. and William D. Zollars) during the last fiscal year, i) was an officer or employee of the Company, or ii) was formerly an officer of the Company.

CORPORATE GOVERNANCE

Code of Business Conduct and Ethics

We have adopted a Code of Conduct for all Cerner employees and Directors (including our Chief Executive Officer, Chief Financial Officer and corporate controller). Any amendments to or waivers of the Code of Conduct applicable to our Chief Executive Officer, Chief Financial Officer or corporate controller will be posted on www.cerner.com. In 2007, the Audit Committee approved amendments to the Code of Conduct to address: i) our Contracting & Signatory Authority Policy; ii) certain non-US policies, procedures and laws and iii) other minor clean-up and clarification items.

Our Corporate Governance Guidelines, the charters of the Audit, Compensation, and Nominating, Governance & Public Policy Committees of the Board, and the Code of Conduct can all be found on our website at www.cerner.com under “About Cerner/Leadership.” Shareholders may also request a free copy of these documents from: Cerner Corporation c/o Secretary, 2800 Rockcreek Parkway, North Kansas City, Missouri 64117.

Majority Voting for Directors

Cerner’s Bylaws provide that, in the case of an uncontested Director election (i.e., where the number of nominees is the same as the number of Directors to be elected), Directors are elected by the affirmative vote of a majority of the votes cast, in person or by proxy, by the holders of outstanding shares of stock entitled to vote for the election of Directors. Any incumbent nominee for Director who fails to receive the requisite majority vote at an annual or special meeting held for the purpose of electing Directors, where the election is uncontested, must promptly -following certification of the shareholder vote — tender his or her resignation to the Board. The independent Directors (excluding the Director who tendered the resignation) will evaluate any such resignation in light of the best interests of Cerner and its shareholders in determining whether to accept or reject the resignation, or whether other action should be taken. In reaching its decision, the Board may consider any factors it deems relevant, including the Director’s qualifications, the Director’s past and expected future contributions to Cerner, the overall composition of the Board and whether accepting the tendered resignation would cause Cerner to fail to meet any applicable rule or regulation (including NASDAQ Stock Market Marketplace Rules and federal securities laws). The Board will act on the tendered resignation, and publicly disclose its decision and rationale, within 90 days following certification of the shareholder vote.

NOMINATING, GOVERNANCE & PUBLIC POLICY COMMITTEE REPORT

The Nominating, Governance & Public Policy Committee (NG&PP Committee) of the Company is currently composed of three independent members of the Board of Directors (all of whom meet the applicable independence requirements of the SEC and The NASDAQ Stock Market Marketplace Rules) and operates under a written charter adopted by the Board of Directors, which charter is available for review on the Company’s website at www.cerner.com under: “About Cerner/Leadership/Nominating, Governance, & Public Policy Committee”. The NG&PP Committee is appointed by the Board to provide assistance to the Board, the Chairman and the CEO of the Company in the areas of: i) Board membership nomination, ii) committee membership selection and rotation practices, iii) evaluation of the overall effectiveness of the Board, iv) review and consideration of developments in corporate governance practices and iv) review and consideration of current and emerging political, corporate citizenship and public policy issues that may affect the business operations, performance or public image of the Company. The NG&PP Committee’s goal is to assure that the composition, practices and operation of the Board contribute to value creation and effective representation of the Company’s shareholders and to foster Cerner’s commitment to operate its business worldwide in a manner consistent with the rapidly changing demands of society.

In 2007, the NG&PP Committee: conducted a self-evaluation by the Board and Board committees; reviewed Board composition, reviewed and recommended Committee member appointments; and, educated itself with respect to the content and operation of the Company’s Corporate Governance, Corporate Policies and Compliance Programs and Board Orientation and Continuing Education Programs. The NG&PP Committee also reviewed Director candidates in accordance with its charter and pursuant to that review, recommended the Director candidates listed in this Proxy as being the nominees best suited to serve the needs of the Company.

Nomination Process and Shareholder Access to Directors

Nominees may be suggested by Directors, members of management, shareholders or, in some cases, by a third party firm. In identifying and considering candidates for nomination to the Board, regardless of the source of the nomination, the NG&PP Committee considers, in addition to the requirements set out in our Corporate Governance Guidelines and the Nominating, Governance & Public Policy Committee Charter, quality of experience, the needs of the Company and the range of talent and experience currently represented on the Board.

In its assessment of each potential candidate, the NG&PP Committee will conduct a background evaluation and review the nominee’s: judgment; character and integrity; experience in business, healthcare, information technology, government and in areas that are relevant to our global activities; independence; understanding of our business or other related industries; and, such other factors the NG&PP Committee determines are pertinent in light of the current needs of the Board. The NG&PP Committee will also take into account the ability of a Director to devote the time and effort necessary to fulfill his or her responsibilities. The NG&PP Committee may use the services of a third-party executive search firm to assist it in identifying and evaluating possible nominees for Director.

As stated above, the NG&PP Committee will consider recommendations for directorships submitted by shareholders. Shareholders who wish the NG&PP Committee to consider their recommendations for nominees for the position of Director should submit their recommendations in writing to the NG&PP Committee in care of the Company’s Secretary, Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City, Missouri 64117. Recommendations by shareholders that are made in accordance with these procedures will receive the same consideration given to other potential nominees considered by the Nominating, Governance & Public Policy Committee. In addition, shareholders may submit Director nominations to the Company in accordance with the procedures described below in “Shareholder Proposals”.

The director nominees up for election at the 2008 Annual Shareholders’ Meeting, as set forth below in Proposal No. 1, were recommended by the NG&PP Committee and nominated for re-election for a three year term by the full Board of Directors.

The Board provides a process for shareholders to send communications to the Board or any of the individual Directors. Shareholders may send written communications to the Board or any of the individual Directors c/o Secretary, Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City, Missouri 64117. All communications will be compiled by our Corporate Secretary and submitted to the Board or the individual Directors, as applicable, on a periodic basis.

Members of the Nominating, Governance & Public Policy Committee:
Gerald E. Bisbee, Jr., Ph.D.
John C. Danforth
William B. Neaves, Ph.D.
___________________

CERTAIN TRANSACTIONS

The Company leases an airplane from PANDI, Inc. (“PANDI”), a company owned by Neal L. Patterson and Clifford W. Illig, the Company’s Chairman of the Board & CEO and Vice Chairman of the Board, respectively. In 2007, the airplane was leased on a per mile basis with no minimum usage guarantee. The lease rate is believed to approximate fair market value for this type of aircraft. During 2007, the Company paid an aggregate of $660,704.25 as leasing fees for use of the airplane. The airplane is used principally by Trace Devanny, President, and Mike Valentine, Executive Vice President, to increase the number of client visits each can make and to reduce the physical strain of their heavy travel schedules. The Company intends to continue the use of the airplane in 2008.

On December 27, 2006 the Audit Committee approved, and on February 6, 2007 the Company entered into, an Aircraft Services Agreement between Rockcreek Aviation, Inc. (the Company’s wholly-owned flight operations subsidiary (“Rockcreek Aviation”)) and PANDI, wherein Rockcreek Aviation will provide flight operation services to PANDI with respect to PANDI’s aircraft. PANDI owns and operates a Beechcraft BeechJet 400 (the “Aircraft”) and PANDI’s sole shareholders are Neal Patterson and Clifford Illig, the Company’s Chairman of the Board & CEO and Vice Chairman of the Board, respectively. During 2007, the flight operations services fees paid by PANDI to the Company were $237,556.42.

Certain executive officers have immediate family members who are employed by the Company. The compensation of each such family member was established by the Company in accordance with the Company’s employment and compensation practices applicable to employees with equivalent qualifications, experience, responsibilities and holding similar positions. Michael R. Nill, the brother of Julia M. Wilson, an executive officer of the Company, is employed by the Company as Sr. Vice President, Technical Architecture. Mr. Nill’s aggregate compensation for the fiscal year 2007 was $596,000. His compensation is not subject to approval by the Board of Directors. On April 24, 2007, Mr. Nill was awarded options under the Company’s Stock Option Plan G to purchase 25,000 shares of the Company’s Common Stock at an exercise price of $54.61 per share, which was the closing price of the Company’s Common Stock on the date the options were granted. The options granted to Mr. Nill vest at various amounts over a period of five years. Dr. David Nill, the brother of Julia M. Wilson, an executive officer of the Company, is employed by Cerner Health Connections, Inc. (a wholly-owned subsidiary of the Company) as Medical Director. Dr. Nill’s aggregate compensation for the fiscal year 2007 was $193,255. Dr. Nill’s compensation is not subject to approval by the Board of Directors. On October 23, 2007 Dr. Nill was awarded options under the Company’s Stock Option Plan G to purchase 380 shares of the Company’s Common Stock at an exercise price of $58.72 per share, which was the closing price of the Company’s Common Stock on the date the options were granted. The options granted to Dr. Nill vest at various amounts over a period of five years.

The Company believes that these various relationships and transactions were reasonable and in the best interests of the Company.

Policies and Procedures for Review and Approval of Transactions with Related Persons

We have established a conflict of interest policy to address instances in which an employee’s or Director’s private interests may conflict with the interests of the Company. We have established an ad hoc management committee, consisting of members from our legal department, to help administer our conflicts policy and to render objective determinations regarding whether any employee’s or Director’s private interests may interfere with the interests of the Company.

Conflicts of interest are also addressed in our Code of Conduct, which is published on our Internet website at www.cerner.com. Any waiver of any provision of our Code of Conduct for executive officers or Directors may be made only by the Board, and will be promptly disclosed as required by law or NASDAQ rule.

We and our auditors, KPMG LLP, solicit information annually from our Directors and executive officers in connection with the preparation of disclosures in our annual Form 10-K and our annual Proxy Statement. These questionnaires specifically seek information pertaining to any “related person” transaction. And, management informs the Board and/or its Committees regarding any potential “related person” transaction (within the meaning of Item 404(a) of the SEC’s Regulation S-K) of which management is aware, and such items are reviewed and approved by the Audit Committee on an annual basis.

VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF

The table below sets forth information, as of March 15, 2008 (unless otherwise indicated below), with respect to the beneficial ownership of shares of Common Stock by: i) each person known to us to own beneficially more than 5% of the aggregate shares of Common Stock outstanding, ii) each Director and nominee for election as a Director, iii) each executive officer named in the Summary Compensation Table and iv) the executive officers and Directors of the Company as a group. Each of the persons, or group of persons, in the table below has sole voting power and sole dispositive power as to all of the shares shown as beneficially owned by them, except as otherwise indicated.


	Amount and Nature of			Percent of Shares
Name and Address of Beneficial Owner	Beneficial Ownership			Outstanding
FMR Corp.		7,414,553	(1)		9.2	%
Neal L. Patterson		7,393,351	(2)		9.2	%
Waddell & Reed Ivy Investment Company		5,762,215	(3)		7.2	%
Clifford W. Illig		4,963,112	(4)		6.3	%
Sands Capital Management		4,958,832	(5)		6.2	%
Wellington Management Company, LLP		4,391,836	(6)		5.5	%
The TCW Group, Inc.		4,209,507	(7)		5.3	%
Capital Group International		4,137,140	(8)		5.2	%
Vanguard Specialized Funds-Vanguard Health Care Fund		4,000,000	(6)		5.0	%
Jeff Townsend		82,254			*
Earl H. Devanny, III		81,885			*
Michael E. Herman		79,700	(9)		*
Marc G. Naughton		78,938			*
John C. Danforth		78,672			*
Gerald E. Bisbee, Jr., Ph.D.		73,200			*
William B. Neaves, Ph.D.		53,500	(10)		*
Nancy-Ann DeParle		27,000			*
William D. Zollars		11,832			*
All Directors and executive officers, as a group (15 persons)		12,991,085			16.2	%


*		Less than one percent.

(1)		Schedule 13G, dated January 9, 2008 and filed by FMR Corp., reported sole voting power with respect to 424,081 shares of Common Stock and sole dispositive power with respect to 7,414,553 shares of Common Stock. The address for FMR Corp. is 82 Devonshire Street, Boston, Massachusetts 02109.

(2)		Includes 833,173 shares held in trust for minor children with Jeanne Lillig-Patterson, wife of Neal L. Patterson, serving as trustee. Excludes 43,686 shares held by Jeanne Lillig-Patterson, wife of Neal L. Patterson, as to which Mr. Patterson disclaims beneficial ownership. The address for Mr. Patterson is Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City, Missouri 64117.

(3)		Schedule 13G, dated February 1, 2008 and filed by Waddell & Reed Financial, Inc. (“WDR”), Waddell & Reed Financial Services, Inc. (“WRFSI”), Waddell & Reed, Inc. (“WRI”), Waddell & Reed Investment Management Company (“WRIMCO”) and Ivy Investment Management Company (“IICO”), collectively (“Waddell”), reported sole voting and dispositive power of the following shares of Common Stock: WDR: 5,762,215 (indirect) WRFSI: 4,998,265 (indirect) WRI: 4,998,265 (indirect) WRIMCO: 4,998,265 (direct) IICO: 763,950 (direct)


		The address for Waddell is 6300 Lamar Avenue, Overland Park, Kansas 66202.

(4)		Includes 391,334 shares held in trust for minor children with Bonnie A. Illig, wife of Clifford W. Illig, serving as trustee. The address for Mr. Illig is Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City, Missouri 64117.

(5)		Schedule 13G, dated February 11, 2008 and filed by Sands Capital Management, LLC, reporting sole voting power with respect to 2,926,805 shares of Common Stock and sole dispositive power with respect to 4,958,832 shares of Common Stock. The address for Sands Capital Management, LLC is 1101 Wilson Blvd., Suite 2300, Arlington, Virginia 22209.

(6)		Schedule 13G, dated February 14, 2008 and filed by Wellington Management Company, LLP (“Wellington”), reported Wellington having shared voting power with respect to 144,400 shares of Common Stock and shared dispositive power with respect to 4,391,836 shares of Common Stock. The Schedule 13G filed by Wellington also reported that Vanguard Specialized Fund — Vanguard Health Care Fund (“Vanguard”) owns more than five percent of these shares. Schedule 13G, dated February 27, 2008 and filed by Vanguard, reported sole voting power with regard to 4,000,000 shares of Common Stock. The address for Wellington Management Company, LLP is 75 State Street, Boston, Massachusetts 02109. The address for Vanguard is 100 Vanguard Blvd., Malvern, Pennsylvania 19355.

(7)		Schedule 13G, dated February 11, 2008 and filed by The TCW Group, Inc., on behalf of the TCW Business Unit, reported shared voting power with respect to 3,419716 shares of Common Stock and shared dispositive power with respect to 4,209,507 shares of Common Stock. The address for TCW Group Inc. is 865 South Figueroa Street, Los Angeles, California 90017.

(8)		Schedule 13G, dated February 8, 2008 and filed by Capital Group International, Inc., reporting sole voting power with respect to 3,381,120 shares of Common Stock and sole dispositive power with respect to 4,137,140 shares of Common Stock. The address for Capital Group International, Inc. is 11100 Santa Monica Blvd., Los Angeles, California 90025.

(9)		Excludes 1,800 shares held by Karen Herman, wife of Michael Herman, as to which Mr. Herman disclaims beneficial ownership. The address for Mr. Herman is Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City, Missouri 64117.

(10)		Includes 13,500 shares held with Priscilla Neaves, wife of William B. Neaves, in Joint Tenancy with Right of Survivorship. The address for Mr. Neaves is Cerner Corporation, 2800 Rockcreek Parkway, North Kansas City, Missouri 64117.

FINANCIAL STATEMENTS

Our Annual Report to Shareholders for the fiscal year ended December 29, 2007 is enclosed with this Proxy Statement.

PROPOSAL NO. 1

ELECTION OF DIRECTORS

There are three nominees for election to the Board this year. John C. Danforth, Neal L. Patterson and William D. Zollars are Class I Directors and have served continuously on our Board since 2005, 1980 and 2005, respectively. The Board has nominated Mr. Danforth, Mr. Patterson and Mr. Zollars for re-election. Unless otherwise instructed, the persons named as proxies will vote for the election of Mr. Danforth, Mr. Patterson and Mr. Zollars. Each of the Director nominees has agreed to be named in this Proxy Statement and to serve if elected.

We know of no reason why any of the nominees would not be able to serve. However, if any nominee is unable or declines to serve as a Director, or if a vacancy occurs before election (which events are not anticipated), the persons named as proxies will vote for the election of such other person or persons as are nominated by the Board.

Information concerning each Director nominee is set forth above, along with information about other members of our Board.

The Company’s Board of Directors unanimously recommends
a vote FOR election of the nominees

RELATIONSHIP WITH INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Our independent registered public accounting firm during the year ended December 29, 2007 was KPMG. KPMG has audited our financial statements since 1983.

Audit and Non-Audit Fees

Audit Fees. Fees paid or payable to KPMG totaled $1,259,370 and $1,053,000 for professional services rendered for the audit of our consolidated financial statements for the years ended December 29, 2007 and December 30, 2006, its reviews of our consolidated financial statements included in our quarterly reports on Form 10-Q, and for routine consultation on accounting and reporting matters that directly affected the consolidated financial statements for the years ended December 29, 2007 and December 30, 2006, respectively. Additionally, KPMG billed us an aggregate of $97,500 and $49,000 for professional services rendered for audits of foreign subsidiaries in support of statutory reporting requirements for the years ended December 29, 2007 and December 30, 2006, respectively.

Audit-Related Fees. There were no audit-related fees paid to KPMG for the years ended December 29, 2007 and December 30, 2006.

Tax Fees. KPMG billed us an aggregate of $212,101 and $272,000 for tax services for the years ended December 29, 2007 and December 30, 2006, respectively, including fees for services relating to tax consultation and tax compliance services.

All Other Fees. There were no other fees paid to KPMG for the years ended December 29, 2007 and December 30, 2006.

The Audit Committee has determined that the provision of services by KPMG described in the preceding paragraphs is compatible with maintaining KPMG’s independence. All permissible non-audit services provided by KPMG in 2007 were pre-approved by the Audit Committee. In addition, no audit engagement hours were spent by people other than KPMG’s full-time, permanent employees.

Pursuant to Section 202 of the Sarbanes-Oxley Act of 2002, our Audit Committee has approved all auditing and non-audit services performed to date and currently planned to be provided related to the fiscal year 2008 by our independent registered public accounting firm, KPMG. The services include the annual audit, quarterly reviews, issuances of consents related to SEC filings and certain tax compliance services.

PROPOSAL NO. 2

RATIFICATION OF THE APPOINTMENT OF KPMG
AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Our Audit Committee has retained the firm of KPMG LLP as our independent registered public accounting firm for fiscal year 2008, and we are asking shareholders to ratify that appointment. In the event the shareholders fail to ratify the appointment, the Audit Committee will reconsider this appointment but will not necessarily select another firm. Even if the appointment is ratified, the Audit Committee, in its discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if the Audit Committee determines that such a change would be in the best interests of the Company and our shareholders. Representatives of KPMG will be present at the Annual Shareholders’ Meeting, have the opportunity to make a statement and be available to answer questions.

The Company’s Board of Directors unanimously recommends
a vote FOR the ratification of the appointment of KPMG LLP
as our independent registered public accounting firm for fiscal year 2008

SHAREHOLDER PROPOSALS

If a shareholder would like to make a proposal at our 2009 annual meeting, including the nomination of a Director candidate, we must receive written notice no later than the close of business on December 18, 2008 in order that it may be considered for including in the proxy statement and form of proxy relating to that meeting. Shareholders wishing to submit proposals or Director nominations that are not to be included in such proxy statement and form of proxy must deliver notice no later than the close of business on January 22, 2009.

The notice must describe the proposed business, the shareholder’s name and address, a description of the class and number of shares of stock of the Company which are beneficially owned (as that term is defined in our Certificate of Incorporation) by the shareholder, any material interest of the shareholder in such business and all other information regarding the proposal which the Company would be required to provide in a proxy statement filed pursuant to the proxy rules of the Securities and Exchange Commission if proxies for the proposal were being solicited by the Company. Such proposals must also comply in full with the requirements of Rule 14a-8 under the Securities Act of 1934 and shareholders are also advised to review our Bylaws, which contain additional requirements with respect to advance notice of shareholder proposals and Director nominations. Notice must be sent to our Corporate Secretary at 2800 Rockcreek Parkway, North Kansas City, Missouri 64117.

Any notice received after January 22, 2009 is untimely. We reserve the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these and other applicable requirements. Nominees recommended by shareholders of the Company in accordance with our advance notice provision will be considered by the Nominating, Governance & Public Policy Committee for recommendation for nomination by the Board.

OTHER MATTERS

We know of no other matters to be brought before the Annual Shareholders’ Meeting. If any other matter properly comes before the Annual Shareholders’ Meeting, it is the intention of the persons named in the enclosed Proxy Card to vote the shares represented by the proxies as the Board may recommend.

BY ORDER OF THE BOARD OF DIRECTORS,

Randy D. Sims

Secretary

North Kansas City, Missouri
April 16, 2008

TO: Cerner Corporation 401(k) Associate Participants
SUBJECT: Cerner 2008 Annual Shareholders’ Meeting: Electronic Voting Instructions

The Annual Shareholders’ Meeting of Cerner Corporation (the “Company”) will be held at 10:00 a.m., local time, on May 23, 2008. You have been enrolled to receive shareholder communications and to submit voting instructions via the Internet.

Please read the following information carefully.

As a participant in the Cerner Corporation Foundations Retirement Plan, you are entitled to instruct Fidelity Management Trust Company (the “Trustee”) to vote the shares of Common Stock of the Company held by you under the Plan as of March 28, 2008. As of March 28, 2008 your Plan account reflected 123,456,789,012.000000 shares of Common Stock.

The number of shares of Common Stock shown includes any shares of Common Stock purchased as either an Associate contribution or Company contribution. Therefore, you may not be vested in the total number of shares of Common Stock indicated.

There are two items for which you may vote: (i) the election of three director nominees to serve for a three-year term; and, (ii) the ratification of the appointment of KPMG LLP as the independent registered public accounting firm of the Company for 2008.

Details about each of these items are provided in the 2008 Proxy Statement.
The Board of Directors recommends that you vote “for” these items.

CONTROL NUMBER: 012345678901

You can enter your voting instructions and view the shareholder material at the following Internet site. If your browser supports secure transactions you will be automatically directed to a secure site.

http://www.proxyvote.com/0012345678901

To access Proxy Vote, you will need the above CONTROL NUMBER and a four digit PIN. The PIN number you will need is the last four digits of your social security number. Internet voting is accepted up to 11:59 p.m., EDT, May 22, 2008.

The 2007 Annual Report and 2008 Proxy Statement can be found at the following Internet site:

http://www.cerner.com/public/Cerner_f2.asp?id=30728

The Company’s 2007 Annual Report and its 2008 Proxy Statement may also be provided, at the participant’s request, in hard copy form. To receive a paper copy of the Company’s 2007 Annual Report and its 2008 Proxy Statement, please contact Joette Krier at(816) 201-1029.

Once you submit your votes the process is complete and your votes will remain confidential. This message and any attachments are intended only for the use of the addressee and may contain information that is privileged and confidential. If the reader of the message is not the intended recipient or an authorized representative of the intended recipient, you are hereby notified that any dissemination of this communication is strictly prohibited. If you have received this communication in error, please notify us immediately by e-mail and delete the message and any attachments from your system.

2800 ROCKCREEK PARKWAY
NORTH KANSAS CITY, MO 64117

VOTE BY INTERNET — www.proxyvote.com

Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time on May 22, 2008. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

ELECTRONIC DELIVERY OF FUTURE SHAREHOLDER COMMUNICATIONS

If you would like to reduce the costs incurred by Cerner Corporation in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access shareholder communications electronically in future years.

VOTE BY PHONE — 1-800-690-6903

Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time on May 22, 2008. Have your proxy card in hand when you call and then follow the instructions.

VOTE BY MAIL

Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Cerner Corporation, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

IF YOU VOTE OVER THE INTERNET OR BY TELEPHONE, PLEASE DO NOT MAIL YOUR CARD.


TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:	CERNR1	KEEP THIS PORTION FOR YOUR RECORDS

		DETACH AND RETURN THIS PORTION ONLY

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.


CERNER CORPORATION		For All		Withhold All		For All Except		To withhold authority to vote for any individual nominee(s), mark “For All Except” and write the number(s) of the nominee(s) on the line below.


THE BOARD OF DIRECTORS RECOMMENDS A VOTE “FOR” PROPOSALS 1 AND 2.
Vote on Directors	o	o	o


1.	ELECTION OF DIRECTORS
	Nominees:
	01) John C. Danforth
	02) Neal L. Patterson
	03) William D. Zollars

Vote on Proposal		For	Against	Abstain

2.	Ratification of the appointment of KPMG LLP as the independent registered public accounting firm of Cerner Corporation for 2008.	o	o	o

(PLEASE SIGN AND DATE BELOW AND MAIL PROMPTLY IN THE ENCLOSED ENVELOPE)

This Proxy, when properly executed, will be voted in the manner directed herein by the undersigned shareholder(s). If no direction is made, this Proxy will be voted “FOR” proposals 1 and 2.

In their discretion, the appointed proxies are to vote upon such other business as may properly come before the meeting which the Board of Directors does not have knowledge of a reasonable period of time before the solicitation of this Proxy.



Signature [PLEASE SIGN WITHIN BOX]	Date	Signature (Joint Owners)	Date

Important Notice Regarding Internet Availability of Proxy Materials for the Annual Meeting:
The Notice and Proxy Statement and Annual Report are available at www.proxyvote.com.


		CERNER CORPORATION 2800 Rockcreek Parkway North Kansas City, Missouri 64117		PROXY

This Proxy is for the 2008 Annual Shareholders’ Meeting of Cerner Corporation, a Delaware corporation, to be held May 23, 2008, at 10:00 a.m., local time, at The Cerner Round auditorium in the Cerner Vision Center, located on the Cerner Campus at 2850 Rockcreek Parkway, North Kansas City, Missouri 64117.

THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS OF CERNER CORPORATION.

The undersigned hereby appoints Clifford W. Illig and Neal L. Patterson, and each of them, jointly and severally, with full power of substitution, as attorneys-in-fact, to vote all the shares of Common Stock which the undersigned is entitled to vote at the 2008 Annual Shareholders’ Meeting of Cerner Corporation to be held on May 23, 2008, and at any adjournment thereof, on the transaction of any and all business which may come before said meeting, as fully and with the same effect as the undersigned might or could do if personally present for the purposes set forth.

The undersigned hereby acknowledges receipt of the Notice of Annual Shareholders’ Meeting, Proxy Statement, dated April 16, 2008, and the 2007 Annual Report to Shareholders.

PLEASE MARK, SIGN, DATE AND MAIL THIS PROXY IN THE ENVELOPE PROVIDED.

CONTINUED AND TO BE SIGNED ON REVERSE SIDE


	1) Title of each class of securities to which transaction applies:


	2) Aggregate number of securities to which transaction applies:


	Page
GENERAL INFORMATION		1
INFORMATION CONCERNING DIRECTORS		4
MEETINGS OF THE BOARD AND COMMITTEES		6
COMMITTEES OF THE BOARD		6
DIRECTOR COMPENSATION		8
AUDIT COMMITTEE REPORT		9
Guidelines of Cerner Corporation’s Audit Committee for Pre-Approval of Independent Auditor Services		10
COMPENSATION COMMITTEE REPORT		11
COMPENSATION DISCUSSION AND ANALYSIS		12
SUMMARY COMPENSATION TABLE		21
GRANTS OF PLAN-BASED AWARDS		22
OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END		23
OPTION EXERCISES		24
EMPLOYMENT AGREEMENTS & POTENTIAL PAYMENTS UNDER TERMINATION OR CHANGE IN CONTROL		24
COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION		30
CORPORATE GOVERNANCE		30
NOMINATING, GOVERNANCE & PUBLIC POLICY COMMITTEE REPORT		31
CERTAIN TRANSACTIONS		32
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE		33
VOTING SECURITIES AND PRINCIPAL HOLDERS THEREOF		34
FINANCIAL STATEMENTS		35
PROPOSAL NO. 1 ELECTION OF DIRECTORS		35
RELATIONSHIP WITH INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM		36
Audit and Non-Audit Fees		36
PROPOSAL NO. 2 RATIFICATION OF THE APPOINTMENT OF KPMG AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM		36
SHAREHOLDER PROPOSALS		37
OTHER MATTERS		37


	1) Amount Previously Paid:


	2) Form, Schedule or Registration Statement No.:


	3) Filing Party:


	4) Date Filed: